0001178913-25-003678 | 10-Q | XBRL Viewer | Solaredge Technologies INC

RESTRUCTURING AND OTHER EXIT ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2025

Restructuring and Related Activities [Abstract]

Schedule of restructuring and other exit charges by reportable segments and type of cost

	Three Months Ended September 30, 2025									Three Months Ended September 30, 2024
	Employee termination costs			Contract termination and other			Total			Employee termination costs		Contract termination and other		Total
Cost of revenues	$	(4	)	$	(14,566	)	$	(14,570	)	$	884	$	326	$	1,210
Research and development		(26	)		-			(26	)		648		-		648
Sales and marketing		114			-			114			468		-		468
General and administrative		133			-			133			172		-		172
Total	$	217		$	(14,566	)	$	(14,349	)	$	2,172	$	326	$	2,498

	Nine Months Ended September 30, 2025								Nine Months Ended September 30, 2024
	Employee termination costs		Contract termination and other			Total			Employee termination costs		Contract termination and other		Total
Cost of revenues	$	470	$	(14,433	)	$	(13,963	)	$	1,738	$	8,622	$	10,360
Research and development		1,214		-			1,214			3,561		248		3,809
Sales and marketing		982		-			982			1,109		-		1,109
General and administrative		1,710		-			1,710			514		118		632
Other operating expenses		-		(3,137	)		(3,137	)		-		-		-
Total	$	4,376	$	(17,570	)	$	(13,194	)	$	6,922	$	8,988	$	15,910

Schedule of liability balance for the restructuring and other exit charges

	Employee termination costs			Contract termination and other
Balance as of December 31, 2024	$	1,073		$	23,933
Charges		4,376			(16,473	)
Cash payments		(5,449	)		(6,315	)
Non-cash utilization and other		-			(1,145	)
Balance as of September 30, 2025	$	-		$	-

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2025

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 7: FAIR VALUE MEASUREMENTS

In accordance with ASC 820, “Fair Value Measurement”, the Company measures its cash equivalents and marketable securities, at fair value using the market approach valuation technique. Cash and cash equivalents are classified within Level 1 because these assets are valued using quoted market prices. Marketable securities and foreign currency derivative contracts are classified within level 2 due to these assets being valued by alternative pricing sources and models utilizing market observable inputs.

The following table sets forth the Company’s assets that were measured at fair value as of September 30, 2025, and December 31, 2024, by level within the fair value hierarchy:

		Fair value measurements as of
Description	Fair Value Hierarchy	September 30, 2025			December 31, 2024
Assets:
Cash and cash equivalents:
Cash	Level 1	$	417,229		$	239,020
Money market mutual funds	Level 1	$	21,070		$	21,075
Deposits	Level 1	$	1,216		$	14,516
Restricted cash	Level 1	$	47,481		$	135,328
Derivative instruments	Level 2	$	2,793		$	1,262
Short-term marketable securities:
Corporate bonds	Level 2	$	46,840		$	289,856
U.S. Treasury securities	Level 2	$	9,242		$	12,594
U.S. Government agency securities	Level 2	$	2,982		$	8,829
Long-term marketable securities:
Corporate bonds	Level 2	$	-		$	36,241
U.S. Government agency securities	Level 2	$	-		$	6,356
Liabilities:
Derivative instruments	Level 2	$	(1,106	)	$	-

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

+ Details

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
CURRENT ASSETS:
Cash and cash equivalents	$ 439,515	$ 274,611
Restricted cash	47,481	135,328
Marketable securities	59,064	311,279
Trade receivables, net of allowances of $20,840 and $43,038, respectively	286,258	160,423
Inventories, net	530,799	645,897
Prepaid expenses and other current assets	404,399	523,027
Total current assets	1,767,516	2,050,565
LONG-TERM ASSETS:
Marketable securities	0	42,597
Property, plant and equipment, net	318,230	343,438
Operating lease right-of-use assets, net	41,937	41,393
Intangible assets, net	7,754	9,666
Goodwill	50,520	48,380
Loan receivables, net	0	45,678
Other long-term assets	46,353	64,736
Total long-term assets	464,794	595,888
Total assets	2,232,310	2,646,453
CURRENT LIABILITIES:
Trade payables	283,505	107,543
Employees and payroll accruals	70,829	76,292
Warranty obligations	111,738	140,249
Deferred revenues and customers advances	45,873	140,870
Accrued expenses and other current liabilities	262,842	246,078
Convertible senior notes, net	0	346,305
Total current liabilities	774,787	1,057,337
LONG-TERM LIABILITIES:
Convertible senior notes, net	331,169	330,006
Warranty obligations	283,106	292,116
Deferred revenues	277,131	231,049
Finance lease liabilities	40,959	39,159
Operating lease liabilities	29,961	30,018
Other long-term liabilities	15,437	8,426
Total long-term liabilities	977,763	930,774
COMMITMENTS AND CONTINGENT LIABILITIES
STOCKHOLDERS’ EQUITY:
Common stock of $0.0001 par value - Authorized: 125,000,000 shares; issued: 59,800,052 shares asof September 30, 2025 and 58,780,490 shares as of December 31, 2024; outstanding: 59,559,546shares as of September 30, 2025 and 58,027,126 shares as of December 31, 2024.	6	6
Additional paid-in capital	1,861,340	1,813,198
Treasury stock, at cost; 240,506 and 753,364 stocks held as of September 30, 2025 and December 31, 2024, respectively	(16,024)	(50,194)
Accumulated other comprehensive loss	(64,044)	(76,477)
Accumulated deficit	(1,301,518)	(1,028,191)
Total stockholders’ equity	479,760	658,342
Total liabilities and stockholders' equity	$ 2,232,310	$ 2,646,453

LOSS PER SHARE (Schedule of Computation of Basic and Diluted Net Earnings (Loss) Per Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Numerator:
Net loss	$ (50,060)	$ (1,230,789)	$ (273,327)	$ (1,518,918)
Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic	59,278,269	57,029,983	58,659,959	56,952,656
Numerator:
Net loss attributable to common stock, diluted	$ (50,060)	$ (1,230,789)	$ (273,327)	$ (1,518,918)
Denominator:
Shares used in computing net loss per share of common stock, diluted	59,278,269	57,029,983	58,659,959	56,952,656
Loss per share:
Basic	$ (0.84)	$ (21.58)	$ (4.66)	$ (26.67)
Diluted	$ (0.84)	$ (21.58)	$ (4.66)	$ (26.67)

RESTRUCTURING AND OTHER EXIT ACTIVITIES (Schedule of Restructuring and Other Exit Charges by Reportable Segments and Type of Cost) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]
Total	$ (14,349)	$ 2,498	$ (13,194)	$ 15,910
Cost of revenues [Member]
Restructuring Cost and Reserve [Line Items]
Total	(14,570)	1,210	(13,963)	10,360
Research and development [Member]
Restructuring Cost and Reserve [Line Items]
Total	(26)	648	1,214	3,809
Selling and marketing [Member]
Restructuring Cost and Reserve [Line Items]
Total	114	468	982	1,109
General and administrative [Member]
Restructuring Cost and Reserve [Line Items]
Total	133	172	1,710	632
Other operating expenses [Member]
Restructuring Cost and Reserve [Line Items]
Total			(3,137)	0
Employee termination costs [Member]
Restructuring Cost and Reserve [Line Items]
Total	217	2,172	4,376	6,922
Employee termination costs [Member] \| Cost of revenues [Member]
Restructuring Cost and Reserve [Line Items]
Total	(4)	884	470	1,738
Employee termination costs [Member] \| Research and development [Member]
Restructuring Cost and Reserve [Line Items]
Total	(26)	648	1,214	3,561
Employee termination costs [Member] \| Selling and marketing [Member]
Restructuring Cost and Reserve [Line Items]
Total	114	468	982	1,109
Employee termination costs [Member] \| General and administrative [Member]
Restructuring Cost and Reserve [Line Items]
Total	133	172	1,710	514
Employee termination costs [Member] \| Other operating expenses [Member]
Restructuring Cost and Reserve [Line Items]
Total			0	0
Contract termination and other [Member]
Restructuring Cost and Reserve [Line Items]
Total	(14,566)	326	(17,570)	8,988
Contract termination and other [Member] \| Cost of revenues [Member]
Restructuring Cost and Reserve [Line Items]
Total	(14,566)	326	(14,433)	8,622
Contract termination and other [Member] \| Research and development [Member]
Restructuring Cost and Reserve [Line Items]
Total	0	0	0	248
Contract termination and other [Member] \| Selling and marketing [Member]
Restructuring Cost and Reserve [Line Items]
Total	0	0	0	0
Contract termination and other [Member] \| General and administrative [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 0	$ 0	0	118
Contract termination and other [Member] \| Other operating expenses [Member]
Restructuring Cost and Reserve [Line Items]
Total			$ (3,137)	$ 0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

OTHER OPERATING EXPENSE (INCOME), NET (Schedule of other operating expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Other Income and Expenses [Abstract]
Impairment of asset-held for sale	$ 0	$ 0	$ 37,050	$ 0
Loss from business disposition	0	0	17,982	0
Loss (gain) from sale of property, plant and equipment	156	(644)	(10,075)	1,838
Impairment of intangible assets and goodwill	0	24,725	0	24,725
Impairment and disposal by abandonment of property, plant and equipment	673	204,888	2,665	206,620
Other	(1,167)	4,960	(5,811)	4,088
Total other operating expense (income), net	$ (338)	$ 233,929	$ 41,811	$ 237,271

GENERAL (Schedule of summary of the revisions made to condensed consolidated statements of loss) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024
Revision Of Prior Period [Line Items]
Revenues	$ 340,177			$ 235,435			$ 849,086	$ 705,239
Gross loss	72,143			(727,794)			121,810	(764,950)
Operating loss	(35,150)			(1,110,734)			(253,369)	(1,444,621)
Net loss	$ (50,060)	$ (124,744)	$ (98,523)	$ (1,230,789)	$ (130,818)	$ (157,311)	$ (273,327)	$ (1,518,918)
EPS, Basic	$ (0.84)			$ (21.58)			$ (4.66)	$ (26.67)
EPS, Diluted	$ (0.84)			$ (21.58)			$ (4.66)	$ (26.67)
As reported
Revision Of Prior Period [Line Items]
Revenues				$ 260,903				$ 730,707
Gross loss				(702,326)				(739,482)
Operating loss				(1,085,266)				(1,419,153)
Net loss				$ (1,205,321)				$ (1,493,450)
EPS, Basic				$ (21.13)				$ (26.22)
EPS, Diluted				$ (21.13)				$ (26.22)
Adjustment
Revision Of Prior Period [Line Items]
Revenues				$ (25,468)				$ (25,468)
Gross loss				(25,468)				(25,468)
Operating loss				(25,468)				(25,468)
Net loss				$ (25,468)				$ (25,468)
EPS, Basic				$ (0.45)				$ (0.45)
EPS, Diluted				$ (0.45)				$ (0.45)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-10

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 10: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3A
-Subparagraph (24)(d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

+ Details

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Statement of Financial Position [Abstract]
Allowance for trade receivable	$ 20,840	$ 43,038
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized shares	125,000,000	125,000,000
Common stock, issued shares	59,800,052	58,780,490
Common stock, outstanding shares	59,559,546	58,027,126
Treasury stock, shares	240,506	753,364

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Fair Values of Outstanding Derivative Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Designated cash flow hedges [Member]
Derivative assets of options and forward contracts:
Total derivative assets	$ 2,793	$ 1,262
Designated cash flow hedges [Member] \| Prepaid expenses and other current assets [Member]
Derivative assets of options and forward contracts:
Total derivative assets	2,774	1,262
Non-designated hedges [Member] \| Prepaid expenses and other current assets [Member]
Derivative assets of options and forward contracts:
Total derivative assets	19	0
Non-designated hedges [Member] \| Accrued expenses and other current liabilities [Member]
Derivative liabilities of options and forward contracts:
Total derivative liabilities	$ (1,106)	$ 0

- Definition

Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.

+ References + Details

- Definition

Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.

+ References + Details

LOSS PER SHARE (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended
	Jul. 31, 2024	Jun. 30, 2024
Earnings Per Share [Abstract]
Proceeds from issuance of note	$ 3,111	$ 25,230

LOSS PER SHARE

9 Months Ended

Sep. 30, 2025

Earnings Per Share [Abstract]

LOSS PER SHARE

NOTE 19: LOSS PER SHARE

The following table presents the computation of basic and diluted loss per share (“EPS”):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Basic and diluted EPS:
Numerator:
Net loss	$	(50,060	)	$	(1,230,789	)	$	(273,327	)	$	(1,518,918	)
Denominator:
Shares used in computing net loss per share of common stock, basic and diluted		59,278,269			57,029,983			58,659,959			56,952,656
Loss per share:
Basic and Diluted	$	(0.84	)	$	(21.58	)	$	(4.66	)	$	(26.67	)

The following outstanding shares of common stock equivalents were excluded from the calculation due to their antidilutive nature:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Stock-based awards		1,154,437		2,552,867		1,698,622		2,055,632
Notes 2025		1,031,132		-		1,170,898		1,510,363
Notes 2029¹		9,819,347		984,342		9,819,347		392,152
Total shares excluded		12,004,916		3,537,209		12,688,867		3,958,147

¹ In conjunction with the issuance of the Notes 2029 in June 2024, the Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. In July 2024, following an additional issuance of the Notes 2029, $3,111 of net proceeds were used to pay the cost of capped call transactions. In accordance with FASB ASC 260, antidilutive contracts, such as purchased call options are excluded from the computation of diluted net income (loss) per share. Accordingly, any potential impact resulting from capped call transaction is excluded from the Company's computation of diluted net income (loss) per share.

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Gains (Losses) on Derivative Instruments Recognized in our Income Statements) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Non Designated Hedging Instruments [Member]
Trading Activity, Gains and Losses, Net [Line Items]
Gains (losses) on derivative instruments	$ 564	$ 0	$ (3,621)	$ 802
Designated Hedging Instruments [Member]
Trading Activity, Gains and Losses, Net [Line Items]
Gains (losses) on derivative instruments	$ 571	$ 1,131	$ 6,869	$ (1,426)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

DEFERRED REVENUES AND CUSTOMERS ADVANCES (Schedule Estimated Revenues Expected To Recognized In Future To Performance Obligations) (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Jun. 30, 2025	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Deferred Revenue Arrangement [Line Items]
Deferred revenues	$ 323,004	$ 285,905	$ 371,919	$ 254,137	$ 251,014	$ 255,443
2025 [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenues	27,141
2026 [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenues	22,673
2027 [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenues	13,962
2028 [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenues	23,848
2029 [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenues	23,728
Thereafter [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenues	$ 211,652

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair values of outstanding derivative instruments

	Balance sheet location	September 30, 2025			December 31, 2024
Derivative assets of options and forward contracts:
Designated cash flow hedges	Prepaid expenses and other current assets	$	2,774		$	1,262
Non-designated hedges	Prepaid expenses and other current assets		19			-
Total derivative assets		$	2,793		$	1,262
Derivative liabilities of options and forward contracts:
Non-designated hedges	Accrued expenses and other current liabilities	$	(1,106	)	$	-

Schedule of gains (losses) on derivative instruments recognized in the consolidated comprehensive income statements

		Three Months Ended September 30,				Nine Months Ended September 30,
	Affected line item	2025		2024		2025			2024
Foreign exchange contracts
Non Designated Hedging Instruments	Condensed Consolidated Statements of Loss - Financial income (expense), net	$	564	$	-	$	(3,621	)	$	802
Designated Hedging Instruments	Condensed Consolidated Statements of Comprehensive Loss - Cash flow hedges	$	571	$	1,131	$	6,869		$	(1,426	)

INVENTORIES, NET (Schedule of Inventories, Net) (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Inventory Disclosure [Abstract]
Raw materials	$ 280,349	$ 209,259
Work in process	0	3,113
Finished goods	250,450	433,525
Total inventories, net	$ 530,799	$ 645,897

STOCK CAPITAL (Tables)

9 Months Ended

Sep. 30, 2025

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of activity in the share options granted to employees and members of board of directors

	Number of options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value
Outstanding as of December 31, 2024		283,419		$	59.16		3.42	$	17
Exercised		(10,400	)		21.23		-		25
Forfeited or expired		(81,832	)		86.86		-		-
Outstanding as of September 30, 2025		191,187		$	49.37		2.58	$	1,578
Vested and expected to vest as of September 30, 2025		191,187		$	49.37		2.58	$	1,578
Exercisable as of September 30, 2025		191,187		$	49.37		2.58	$	1,578

Schedule of RSU activity

	RSU					PSU
	Number of Shares Outstanding			Weighted average grant date fair value		Number of Shares Outstanding			Weighted average grant date fair value
Unvested as of December 31, 2024		3,395,347		$	70.62		334,254		$	67.52
Granted		2,234,425			15.64		769,938			6.39
Vested		(1,009,162	)		79.56		-			-
Forfeited		(755,078	)		67.99		(206,808	)		70.67
Unvested as of September 30, 2025		3,865,532		$	37.02		897,384		$	14.35

Schedule of recognized stock-based compensation expenses

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Stock-based compensation expenses:
Cost of revenues	$	3,959	$	6,038	$	12,335	$	18,224
Research and development		10,681		17,115		36,448		51,893
Sales and marketing		4,348		6,816		13,432		22,876
General and administrative		2,897		6,672		10,357		19,825
Total stock-based compensation expenses	$	21,885	$	36,641	$	72,572	$	112,818

Stock-based compensation capitalized:
Inventory	$	300	$	722	$	1,379	$	2,387
Other long-term assets		382		508		1,214		1,451
Total stock-based compensation capitalized	$	682	$	1,230	$	2,593	$	3,838

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

SEGMENT INFORMATION (Schedule of Reportable Segments and Operating Income) (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2025

Sep. 30, 2024

Sep. 30, 2025

Sep. 30, 2024

Segment Reporting Information [Line Items]

Revenues

$ 340,177

$ 235,435

$ 849,086

$ 705,239

Less:

Direct costs of goods

183,007

172,735

487,875

417,095

Salaries

^[1]

102,547

127,643

328,657

392,290

Inventory costs

(10,117)

656,495

(10,007)

666,246

Shipment and logistics

14,103

23,505

29,983

64,497

Warranty

25,309

33,192

36,684

76,454

Depreciation and amortization

13,849

13,529

42,980

39,111

Directly related overhead costs

15,975

13,248

42,608

40,797

Other

^[2]

45,665

309,750

154,521

438,747

Financial (income) expense, net

(3,040)

(5,558)

(5,785)

2,371

Income taxes

2,563

121,108

13,946

85,109

Net loss from equity method investments

376

577

951

1,440

Net loss

$ (50,060)

$ (1,230,789)

$ (273,327)

$ (1,518,918)

[1]	Including stock-based compensation expenses.
[2]	Represents indirect costs of goods, consultants and sub-contractors, marketing, bad debt and impairments and dispositions.

GENERAL

9 Months Ended

Sep. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GENERAL

NOTE 1: GENERAL

SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell intelligent inverter solutions designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughout each and every module through constant tracking of maximum power points individually per module, (ii) inverters which invert direct current (“DC”) from the PV modules to alternating current (“AC”), including the Company’s future ready Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup capabilities, and optional connection to the Company's smart EV charger, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners to monitor and manage the solar PV system, (iv) batteries for PV applications that are used to increase energy independence and maximize self-consumption for PV system's owners including a battery and (v) additional smart energy management solutions.

The Company and its subsidiaries sell products worldwide through large distributors, electrical equipment wholesalers, directly to large solar installers and engineering, procurement, and construction firms. The Company has expanded its activity to other areas of smart energy technology both organically and through acquisitions.

Basis of Presentation:

The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.

The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2024, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 25, 2025, have been applied consistently in these unaudited interim condensed consolidated financial statements. Certain prior year amounts have been reclassified to conform to current year presentation.

Trade receivables:

Trade receivables are stated net of credit losses allowance. The Company is exposed to credit losses primarily through sales of products. The allowance against gross trade receivables reflects the current expected credit loss inherent in the receivables portfolio determined based on the Company’s methodology. The Company’s methodology is based on historical collection experience, customer creditworthiness, current and future economic condition and market condition. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Trade receivables are written off after all reasonable means to collect the full amount have been exhausted.

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of trade receivables to present the net amount expected to be collected:

Balance as of January 1, 2025	$	43,038
Increase in provision for expected credit losses		8,671
Recoveries collected		(23,445	)
Amounts written off charged against the allowance		(9,363	)
Foreign currency translation		1,939
Balance as of September 30, 2025	$	20,840

Use of estimates:

The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, government grants, income taxes and related disclosures in the accompanying notes. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.

Concentrations of supply risks:

The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs.

As of September 30, 2025 two contract manufacturers jointly accounted for 48.1% of the Company’s total trade payables.

As of December 31, 2024, two contract manufacturers jointly accounted for 43.4% of the Company’s total trade payables.

The Company's own manufacturing facility, Sella 1, located in the North of Israel, is also used in the Company's ongoing operations.

f. Investment in privately-held companies:

The Company's equity investments are investments in equity securities of privately-held companies, that are not traded and therefore not supported with observable market prices. The Company elected to account for its equity investments without readily determinable market values that either (i) do not meet the definition of in-substance common stock or (ii) do not provide the Company with control or significant influence using Accounting Standards Update (“ASU”) 2016-01.

The Company accounts for equity investments through which it exercise significant influence but do not have control over the investee under the equity method. Under this method, the investment, which was initially recorded at cost, is adjusted to recognize the Company’s share of net earnings or losses of the investee as they occur, rather than when dividends or other distributions are received.

The Company adjusts the carrying value of its investments to fair value upon observable transactions for identical or similar investments of the same issuer.

The Company periodically evaluates the carrying value of the investments in privately-held companies when events and circumstances indicate that the carrying amount of the investment may not be recovered. The maximum loss the Company can incur for its investments is their carrying value.

The Company may determine the fair value by reviewing equity valuation reports, current financial results, long-term plans of the privately-held companies, the amount of cash that the privately-held companies have on-hand, the ability to obtain additional financing and overall market conditions in which the privately-held companies operate or based on the price observed from the most recent completed financing.

All gains and losses, whether due to an impairment or revaluation, on investments in privately-held companies, realized and unrealized, are recognized in other income (expense), net.

During the three and nine months ended September 30, 2025, the Company determined that an other-than-temporary impairment had occurred in its investment in Ampeers Energy GmbH ("Ampeers"). Accordingly, the Company reduced the carrying amount of its investment to its estimated fair value and recognized an impairment loss of $15,057.

New accounting standards updates:

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). ASU 2023-09 requires additional categories of information about federal, state and foreign income taxes to be included in effective tax rate reconciliation disclosure. Additionally, the newly added categories also apply to the income taxes paid disclosure. Implementation of said additions are subject to quantitative thresholds. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact from ASU 2023-09 on its consolidated financial statements disclosures.

In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): “Disaggregation of Income (loss) Statement Expenses” (“ASU 2024-03”). ASU 2024-03 requires disaggregation of certain costs and expenses included in each relevant expense caption on the Company's consolidated income (loss) statements in a separate note to the financial statements at each interim and annual reporting period, including amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization. ASU 2024-04 is effective fiscal years beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact from ASU 2024-03 on its consolidated financial statements disclosures.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. This amendment introduces a practical expedient for the application of the current expected credit loss (“CECL”) model to current accounts receivable and contract assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the timing of adoption and impact of this amendment on its Consolidated Financial Statements and related disclosures.

In September 2025, the FASB issued ASU 2025-06, “Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software” (“ASU 2025-06”), which simplifies the capitalization guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted. ASU 2025-06 permits an entity to apply the new guidance using a prospective, retrospective or modified transition approach. The Company is currently evaluating the impact from ASU 2025-06 on its consolidated financial statements.

Revision to previously issued financial statements:

Subsequent to filing Form 10-Q for the third quarter of 2024, the Company identified an immaterial error related to an amended agreement with a customer, which was signed on December 21, 2024, resulting in an overstatement of loans receivables and revenues as of and for the three and nine months ended September 30, 2024.

The Company has adjusted the relevant previously reported financial information for such immaterial revision, for the three and nine months ended September 30, 2024, as applicable.

The following table provides a summary of the revisions made to the Company’s condensed consolidated statements of loss, for the periods presented:

	Three Months Ended September 30, 2024									Nine Months Ended September 30, 2024
	As reported			Adjustment			As revised			As reported			Adjustment			As revised
Revenues	$	260,903		$	(25,468	)	$	235,435		$	730,707		$	(25,468	)	$	705,239
Gross loss	$	(702,326	)	$	(25,468	)	$	(727,794	)	$	(739,482	)	$	(25,468	)	$	(764,950	)
Operating loss	$	(1,085,266	)	$	(25,468	)	$	(1,110,734	)	$	(1,419,153	)	$	(25,468	)	$	(1,444,621	)
Net loss	$	(1,205,321	)	$	(25,468	)	$	(1,230,789	)	$	(1,493,450	)	$	(25,468	)	$	(1,518,918	)
EPS	$	(21.13	)	$	(0.45	)	$	(21.58	)	$	(26.22	)	$	(0.45	)	$	(26.67	)

The following table provides a summary of the revisions made to the Company’s condensed consolidated statements of cash flows for the period presented:

	Nine Months Ended September 30, 2024
	As reported			Adjustment			As revised
Cash flows provided by operating activities:
Net loss	$	(1,493,450	)	$	(25,468	)	$	(1,518,918	)
Net cash used in operating activities	$	(325,656	)	$	(25,468	)	$	(351,124	)
Net cash provided by investing activities	$	318,755		$	25,468		$	344,223

The following table provides a summary of the revisions made to the Company’s condensed consolidated statements of stockholders' equity for the period presented:

	As of September 30, 2024
	As reported			Adjustment			As revised
Accumulated deficit	$	(715,284	)	$	(25,468	)	$	(740,752	)
Total stockholders’ equity	$	956,366		$	(25,468	)	$	930,898

INVENTORIES, NET (Tables)

9 Months Ended

Sep. 30, 2025

Inventory Disclosure [Abstract]

Schedule of inventories, net

	September 30, 2025		December 31, 2024
Raw materials	$	280,349	$	209,259
Work in process		-		3,113
Finished goods		250,450		433,525
Total inventories, net	$	530,799	$	645,897

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

9 Months Ended

Sep. 30, 2025

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

NOTE 10: ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

	September 30, 2025		December 31, 2024
Accrued expenses	$	184,758	$	166,699
Government authorities		22,364		51,705
Operating lease liabilities		13,717		11,861
Accrual for sales incentives		23,481		11,671
Provision for legal claims		11,648		350
Other		6,874		3,792
Total accrued expenses and other current liabilities	$	262,842	$	246,078

WARRANTY OBLIGATIONS

9 Months Ended

Sep. 30, 2025

Product Warranties Disclosures [Abstract]

WARRANTY OBLIGATIONS

NOTE 8: WARRANTY OBLIGATIONS

Changes in the Company’s product warranty obligations for the three and nine months ended September 30, 2025 and 2024, were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Balance, at the beginning of the period	$	397,564		$	490,832		$	432,365		$	518,244
Accruals for warranty during the period		20,177			15,981			54,271			47,320
Changes in estimates		4,143			6,878			(557	)		16,188
Settlements		(27,040	)		(34,787	)		(91,235	)		(102,848	)
Balance, at end of the period		394,844			478,904			394,844			478,904
Less current portion		(111,738	)		(163,561	)		(111,738	)		(163,561	)
Long term portion	$	283,106		$	315,343		$	283,106		$	315,343

MARKETABLE SECURITIES (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Proceeds from sales of available-for-sale marketable securities	$ 76,288	$ 18,724	$ 76,288	$ 70,642
Realized gains		$ 777		$ 2,747

GENERAL (Schedule of deducted from amortized cost basis of trade receivables) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2025 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Beginning Balance	$ 43,038
Increase in provision for expected credit losses	8,671
Recoveries collected	(23,445)
Amounts written off charged against the allowance	(9,363)
Foreign currency translation	1,939
Ending Balance	$ 20,840

OTHER LONG TERM LIABILITIES (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Tax liabilities	$ 10,331	$ 0
Long term accrued expenses	1,510	0
Accrued severance pay	2,415	6,079
Other	1,181	2,347
Other non-current liabilities	$ 15,437	$ 8,426

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Sep. 15, 2025	Sep. 30, 2025
Guarantor Obligations [Line Items]
Non-cancelable purchase obligations		$ 530,674
Provision for loss		25,493
Contractual obligations for capital expenditures		$ 26,513
Other Commitments		i) order the Company to resume supply of spare parts and technical assistance activities in favor of Stellantis; and ii) to order the Company to pay a penalty of 100,000 Euro for each day of delay in fulfilling the order above. At a hearing on February 25, 2025 the parties discussed the case. On May 8, 2025, the court denied Stellantis’ request for injunction and on May 23, 2025 Stellantis appealed.
Legal claims for accrual		$ 11,648
Ampt, LLC (“Ampt”) [Member]
Guarantor Obligations [Line Items]
Lawsuit claims	$ 54
Damages sought, period	5 years
Projects with customers [Member]
Guarantor Obligations [Line Items]
Guarantees amount		43,455
Office rent lease agreements [Member]
Guarantor Obligations [Line Items]
Guarantees amount		4,564
Other transactions [Member]
Guarantor Obligations [Line Items]
Guarantees amount		$ 1,522

WARRANTY OBLIGATIONS (Tables)

9 Months Ended

Sep. 30, 2025

Product Warranties Disclosures [Abstract]

Schedule of warranty obligations

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Balance, at the beginning of the period	$	397,564		$	490,832		$	432,365		$	518,244
Accruals for warranty during the period		20,177			15,981			54,271			47,320
Changes in estimates		4,143			6,878			(557	)		16,188
Settlements		(27,040	)		(34,787	)		(91,235	)		(102,848	)
Balance, at end of the period		394,844			478,904			394,844			478,904
Less current portion		(111,738	)		(163,561	)		(111,738	)		(163,561	)
Long term portion	$	283,106		$	315,343		$	283,106		$	315,343

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

9 Months Ended

Sep. 30, 2025

Accumulated Other Comprehensive Income Loss [Abstract]

Schedule of changes in AOCI

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Unrealized gains (losses) on available-for-sale marketable securities
Beginning balance	$	207		$	(3,465	)	$	(385	)	$	(4,960	)
Revaluation		50			4,571			642			8,304
Tax on revaluation		-			(1,017	)		-			(1,786	)
Other comprehensive income before reclassifications		50			3,554			642			6,518
Reclassification		2			(777	)		2			(2,747	)
Tax on reclassification		-			198			-			699
Gains reclassified from accumulated other comprehensive income (loss)		2			(579	)		2			(2,048	)
Net current period other comprehensive income		52			2,975			644			4,470
Ending balance	$	259		$	(490	)	$	259		$	(490	)
Unrealized gains (losses) on cash flow hedges
Beginning balance	$	5,371		$	407		$	1,262		$	3,940
Revaluation		1,003			1,286			7,599			(1,620	)
Tax on revaluation		(432	)		(155	)		(730	)		194
Other comprehensive losses (gains) before reclassifications		571			1,131			6,869			(1,426	)
Reclassification		(3,600	)		(646	)		(6,087	)		(1,755	)
Tax on reclassification		432			78			730			211
Gains reclassified from accumulated other comprehensive income (loss)		(3,168	)		(568	)		(5,357	)		(1,544	)
Net current period other comprehensive income (loss)		(2,597	)		563			1,512			(2,970	)
Ending balance	$	2,774		$	970		$	2,774		$	970
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
Beginning balance	$	(77,886	)	$	(64,298	)	$	(78,714	)	$	(43,335	)
Revaluation		(134	)		13,555			694			(7,408	)
Ending balance	$	(78,020	)	$	(50,743	)	$	(78,020	)	$	(50,743	)
Unrealized gains (losses) on foreign currency translation
Beginning balance	$	14,440		$	(10,594	)	$	1,360		$	(2,530	)
Revaluation		(3,497	)		3,604			9,583			(4,460	)
Ending balance	$	10,943		$	(6,990	)	$	10,943		$	(6,990	)
Total	$	(64,044	)	$	(57,253	)	$	(64,044	)	$	(57,253	)

Schedule of reclassifications out of AOCI

Details about Accumulated Other Comprehensive Loss Components	Three Months Ended September 30,						Nine Months Ended September 30,						Affected Line Item in the Statement of Loss
	2025			2024			2025			2024
Unrealized gains (losses) on available-for-sale marketable securities
	$	(2	)	$	777		$	(2	)	$	2,747		Financial income (expense), net
		-			(198	)		-			(699	)	Income taxes
	$	(2	)	$	579		$	(2	)	$	2,048		Total, net of income taxes
Unrealized gains (losses) on cash flow hedges, net
		614			78			1,046			204		Cost of revenues
		1,937			369			3,231			1,031		Research and development
		474			85			791			231		Sales and marketing
		575			114			1,019			289		General and administrative
	$	3,600		$	646		$	6,087		$	1,755		Total, before income taxes
		(432	)		(78	)		(730	)		(211	)	Income taxes
		3,168			568			5,357			1,544		Total, net of income taxes
Total reclassifications for the period	$	3,166		$	1,147		$	5,355		$	3,592

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2025

Fair Value Disclosures [Abstract]

Schedule of assets and liabilities measured at fair value

		Fair value measurements as of
Description	Fair Value Hierarchy	September 30, 2025			December 31, 2024
Assets:
Cash and cash equivalents:
Cash	Level 1	$	417,229		$	239,020
Money market mutual funds	Level 1	$	21,070		$	21,075
Deposits	Level 1	$	1,216		$	14,516
Restricted cash	Level 1	$	47,481		$	135,328
Derivative instruments	Level 2	$	2,793		$	1,262
Short-term marketable securities:
Corporate bonds	Level 2	$	46,840		$	289,856
U.S. Treasury securities	Level 2	$	9,242		$	12,594
U.S. Government agency securities	Level 2	$	2,982		$	8,829
Long-term marketable securities:
Corporate bonds	Level 2	$	-		$	36,241
U.S. Government agency securities	Level 2	$	-		$	6,356
Liabilities:
Derivative instruments	Level 2	$	(1,106	)	$	-

GENERAL (Tables)

9 Months Ended

Sep. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of allowance for credit losses

Balance as of January 1, 2025	$	43,038
Increase in provision for expected credit losses		8,671
Recoveries collected		(23,445	)
Amounts written off charged against the allowance		(9,363	)
Foreign currency translation		1,939
Balance as of September 30, 2025	$	20,840

Summary of the revisions made to the condensed consolidated statements

	Three Months Ended September 30, 2024									Nine Months Ended September 30, 2024
	As reported			Adjustment			As revised			As reported			Adjustment			As revised
Revenues	$	260,903		$	(25,468	)	$	235,435		$	730,707		$	(25,468	)	$	705,239
Gross loss	$	(702,326	)	$	(25,468	)	$	(727,794	)	$	(739,482	)	$	(25,468	)	$	(764,950	)
Operating loss	$	(1,085,266	)	$	(25,468	)	$	(1,110,734	)	$	(1,419,153	)	$	(25,468	)	$	(1,444,621	)
Net loss	$	(1,205,321	)	$	(25,468	)	$	(1,230,789	)	$	(1,493,450	)	$	(25,468	)	$	(1,518,918	)
EPS	$	(21.13	)	$	(0.45	)	$	(21.58	)	$	(26.22	)	$	(0.45	)	$	(26.67	)

	Nine Months Ended September 30, 2024
	As reported			Adjustment			As revised
Cash flows provided by operating activities:
Net loss	$	(1,493,450	)	$	(25,468	)	$	(1,518,918	)
Net cash used in operating activities	$	(325,656	)	$	(25,468	)	$	(351,124	)
Net cash provided by investing activities	$	318,755		$	25,468		$	344,223

	As of September 30, 2024
	As reported			Adjustment			As revised
Accumulated deficit	$	(715,284	)	$	(25,468	)	$	(740,752	)
Total stockholders’ equity	$	956,366		$	(25,468	)	$	930,898

GENERAL (Schedule of summary of the revisions made to condensed consolidated statements of cash flows) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024
Cash flows provided by operating activities:
Net loss	$ (50,060)	$ (124,744)	$ (98,523)	$ (1,230,789)	$ (130,818)	$ (157,311)	$ (273,327)	$ (1,518,918)
Net cash used in operating activities							51,632	(351,124)
Net cash provided by investing activities							$ 371,781	344,223
As reported
Cash flows provided by operating activities:
Net loss				(1,205,321)				(1,493,450)
Net cash used in operating activities								(325,656)
Net cash provided by investing activities								318,755
Adjustment
Cash flows provided by operating activities:
Net loss				$ (25,468)				(25,468)
Net cash used in operating activities								(25,468)
Net cash provided by investing activities								$ 25,468

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands

Common Stock [Member]

Additional paid in capital [Member]

Treasury stock [Member]

Accumulated other comprehensive loss [Member]

Accumulated deficit [Member]

Total

Balance at Dec. 31, 2023

$ 6

$ 1,680,622

$ 0

$ (46,885)

$ 778,166

$ 2,411,909

Balance (in shares) at Dec. 31, 2023

57,123,437

Issuance of common stock upon exercise of stock-based awards

$ 0

^[1]

Issuance of common stock upon exercise of stock-based awards (in shares)

175,254

Stock based compensation

$ 0

38,888

Repurchase of common stock

$ 0

^[1]

(33,222)

Repurchase of common stock (in shares)

(505,896)

Other comprehensive loss adjustments

$ 0

(19,726)

Net loss

(157,311)

Balance at Mar. 31, 2024

$ 6

1,719,523

(33,222)

(66,611)

620,855

2,240,551

Balance (in shares) at Mar. 31, 2024

56,792,795

Balance at Dec. 31, 2023

$ 6

1,680,622

(46,885)

778,166

2,411,909

Balance (in shares) at Dec. 31, 2023

57,123,437

Other comprehensive loss adjustments

(10,368)

Net loss

(1,518,918)

Balance at Sep. 30, 2024

$ 6

1,779,212

(50,315)

(57,253)

(740,752)

930,898

Balance (in shares) at Sep. 30, 2024

57,182,072

Balance at Mar. 31, 2024

$ 6

1,719,523

(33,222)

(66,611)

620,855

2,240,551

Balance (in shares) at Mar. 31, 2024

56,792,795

Issuance of common stock upon exercise of stock-based awards

$ 0

^[1]

Issuance of common stock upon exercise of stock-based awards (in shares)

161,549

Issuance of common stock under employee stock purchase plan (512,858 shares transferred from treasury stock)

$ 0

^[1]

10,208

Issuance of common stock under employee stock purchase plan (512,858 shares transferred from treasury stock) (in shares)

245,146

Stock based compensation

$ 0

39,897

Repurchase of common stock

$ 0

^[1]

(17,093)

Repurchase of common stock (in shares)

(247,468)

Capped call transactions related to Notes 2029

$ 0

(25,230)

Other comprehensive loss adjustments

(11,339)

Net loss

(130,818)

Balance at Jun. 30, 2024

$ 6

1,744,411

(50,315)

(77,950)

490,037

2,106,189

Balance (in shares) at Jun. 30, 2024

56,952,022

Issuance of common stock upon exercise of stock-based awards

$ 0

^[1]

Issuance of common stock upon exercise of stock-based awards (in shares)

230,050

Stock based compensation

$ 0

37,871

Capped call transactions related to Notes 2029

(3,112)

Other comprehensive loss adjustments

20,697

Net loss

(1,230,789)

Balance at Sep. 30, 2024

$ 6

1,779,212

(50,315)

(57,253)

(740,752)

930,898

Balance (in shares) at Sep. 30, 2024

57,182,072

Balance at Dec. 31, 2024

$ 6

1,813,198

(50,194)

(76,477)

(1,028,191)

658,342

Balance (in shares) at Dec. 31, 2024

58,027,126

Issuance of common stock upon exercise of stock-based awards

$ 0

^[1]

Issuance of common stock upon exercise of stock-based awards (in shares)

263,327

Stock based compensation

$ 0

32,511

Other comprehensive loss adjustments

1,873

Net loss

(98,523)

Balance at Mar. 31, 2025

$ 6

1,845,719

(50,194)

(74,604)

(1,126,714)

594,213

Balance (in shares) at Mar. 31, 2025

58,290,453

Balance at Dec. 31, 2024

$ 6

1,813,198

(50,194)

(76,477)

(1,028,191)

658,342

Balance (in shares) at Dec. 31, 2024

58,027,126

Other comprehensive loss adjustments

12,433

Net loss

(273,327)

Balance at Sep. 30, 2025

$ 6

1,861,340

(16,024)

(64,044)

(1,301,518)

479,760

Balance (in shares) at Sep. 30, 2025

59,559,546

Balance at Mar. 31, 2025

$ 6

1,845,719

(50,194)

(74,604)

(1,126,714)

594,213

Balance (in shares) at Mar. 31, 2025

58,290,453

Issuance of common stock upon exercise of stock-based awards

$ 0

^[1]

Issuance of common stock upon exercise of stock-based awards (in shares)

330,739

Issuance of common stock under employee stock purchase plan (512,858 shares transferred from treasury stock)

$ 0

^[1]

(27,243)

34,170

6,927

Issuance of common stock under employee stock purchase plan (512,858 shares transferred from treasury stock) (in shares)

512,858

Stock based compensation

$ 0

20,087

Other comprehensive loss adjustments

16,736

Net loss

(124,744)

Balance at Jun. 30, 2025

$ 6

1,838,563

(16,024)

(57,868)

(1,251,458)

513,219

Balance (in shares) at Jun. 30, 2025

59,134,050

Issuance of common stock upon exercise of stock-based awards

$ 0

^[1]

210

Issuance of common stock upon exercise of stock-based awards (in shares)

425,496

Stock based compensation

$ 0

22,567

Other comprehensive loss adjustments

(6,176)

Net loss

(50,060)

Balance at Sep. 30, 2025

$ 6

$ 1,861,340

$ (16,024)

$ (64,044)

$ (1,301,518)

$ 479,760

Balance (in shares) at Sep. 30, 2025

59,559,546

[1]	Represents an amount less than $1.

ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Changes in AOCI) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024
Accumulated Other Comprehensive (Loss) Income [Line Items]
Beginning balance			$ (76,477)				$ (76,477)
Reclassification				$ 777				$ 2,747
Net current period other comprehensive income (loss)	$ (6,176)	$ 16,736	1,873	20,697	$ (11,339)	$ (19,726)	12,433	(10,368)
Ending balance	(64,044)			(57,253)			(64,044)	(57,253)
Unrealized gains (losses) on available-for-sale marketable securities [Member]
Accumulated Other Comprehensive (Loss) Income [Line Items]
Beginning balance	207		(385)	(3,465)		(4,960)	(385)	(4,960)
Revaluation	50			4,571			642	8,304
Tax on revaluation	0			(1,017)			0	(1,786)
Other comprehensive losses (gains) before reclassifications	50			3,554			642	6,518
Reclassification	2			(777)			2	(2,747)
Tax on reclassification	0			198			0	699
Gains reclassified from accumulated other comprehensive income (loss)	2			(579)			2	(2,048)
Net current period other comprehensive income (loss)	52			2,975			644	4,470
Ending balance	259	207		(490)	(3,465)		259	(490)
Unrealized gains (losses) on cash flow hedges [Member]
Accumulated Other Comprehensive (Loss) Income [Line Items]
Beginning balance	5,371		1,262	407		3,940	1,262	3,940
Revaluation	1,003			1,286			7,599	(1,620)
Tax on revaluation	(432)			(155)			(730)	194
Other comprehensive losses (gains) before reclassifications	571			1,131			6,869	(1,426)
Reclassification	(3,600)			(646)			(6,087)	(1,755)
Tax on reclassification	432			78			730	211
Gains reclassified from accumulated other comprehensive income (loss)	(3,168)			(568)			(5,357)	(1,544)
Net current period other comprehensive income (loss)	(2,597)			563			1,512	(2,970)
Ending balance	2,774	5,371		970	407		2,774	970
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature [Member]
Accumulated Other Comprehensive (Loss) Income [Line Items]
Beginning balance	(77,886)		(78,714)	(64,298)		(43,335)	(78,714)	(43,335)
Revaluation	(134)			13,555			694	(7,408)
Ending balance	(78,020)	(77,886)		(50,743)	(64,298)		(78,020)	(50,743)
Unrealized gains (losses) on foreign currency translation [Member]
Accumulated Other Comprehensive (Loss) Income [Line Items]
Beginning balance	14,440		$ 1,360	(10,594)		$ (2,530)	1,360	(2,530)
Revaluation	(3,497)			3,604			9,583	(4,460)
Ending balance	$ 10,943	$ 14,440		$ (6,990)	$ (10,594)		$ 10,943	$ (6,990)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (273,327)	$ (1,518,918)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	23,430	47,215
Loss on impairment and disposal of property, plant and equipment	2,665	206,620
Provision To Write Down Inventories To Net Realizable Value	12,533	638,966
Impairment of asset held-for-sale	36,277	0
Impairment of goodwill and intangible assets	0	24,725
Impairment of privately-held companies	15,057	5,000
Stock-based compensation expenses	72,572	112,818
Loss from business disposition	17,875	0
Deferred income taxes, net	(976)	79,831
Gain from repurchasing of convertible notes	0	(15,455)
Loss from exchange rate fluctuations	2,874	8,243
Loss (gain) from sale of property, plant and equipment	(10,075)	1,838
Other items	(1,408)	3,461
Changes in assets and liabilities:
Trade receivables, net	(124,459)	379,214
Inventories, net	117,875	15,858
Prepaid expenses and other assets	58,655	74,108
Operating lease right-of-use assets, net	8,185	12,286
Trade payables	175,906	(385,342)
Warranty obligations	(37,316)	(39,294)
Deferred revenues and customers advances	(46,597)	1,253
Operating lease liabilities	(10,051)	(11,881)
Accrued expenses and other liabilities	11,937	8,330
Net cash provided by (used in) operating activities	51,632	(351,124)
Cash flows from investing activities:
Investment in available-for-sale marketable securities	(454,635)	(200,919)
Proceeds from maturities of available-for-sale marketable securities	682,866	632,866
Proceeds from sales of available-for-sale marketable securities	76,288	70,642
Purchase of property, plant and equipment	(14,174)	(95,905)
Business combinations, net of cash acquired	0	(10,417)
Proceeds from sale of investment in privately-held company	4,000	0
Business dispositions, net of cash sold	(7,322)	(2,598)
Proceeds from sale of property, plant and equipment	38,026	1,733
Repayment related to governmental grant	(6,643)	0
Purchase of intangible assets	0	(10,000)
Disbursements for loans receivables	0	(37,500)
Investment in privately-held companies	(300)	(25,742)
Proceeds from loan receivables	50,743	27,092
Other investing activities	2,932	(5,029)
Net cash provided by investing activities	371,781	344,223
Cash flows from financing activities:
Repurchase of common stock	0	(50,315)
Proceeds from issuance of Notes 2029, net of issuance costs	0	329,214
Capped call transactions related to Notes 2029	0	(28,342)
Payment for settlement of convertible notes	(342,250)	0
Repurchase of convertible debt	(5,093)	(267,900)
Other financing activities	(2,194)	(2,530)
Net cash used in financing activities	(349,537)	(19,873)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,181	(7,790)
Increase (decrease) in cash, cash equivalents and restricted cash	77,057	(34,564)
Cash, cash equivalents and restricted cash, beginning of period	409,939	338,468
Cash, cash equivalents and restricted cash, end of period	$ 486,996	$ 303,904

SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

SEGMENT INFORMATION

NOTE 20: SEGMENT INFORMATION

Following the sale of Automation Machines and the discontinuation of the Company's Energy Storage activity, in 2024, the Company now operates as one operating segment that constitutes consolidated results. The Company recast its comparative numbers to conform to current period presentation.

The Company's Chief Executive Officer, who is the chief operating decision maker (“CODM”), makes resource allocation decisions and assesses performance based on financial information presented on a consolidated net loss, accompanied by disaggregated information about significant expenses.

The Company’s CODM does not regularly review asset information and, therefore, the Company does not report asset information.

The segment includes the design, development, manufacturing, and sales of an intelligent inverter solution designed to maximize power generation at the individual PV module level and batteries for PV applications. The segment solution consists mainly of the Company’s power optimizers, inverters, batteries and cloud‑based monitoring platform.

The following tables present information on reportable loss for the period presented:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Revenues	$	340,177		$	235,435		$	849,086		$	705,239
Less:
Direct costs of goods		183,007			172,735			487,875			417,095
Salaries¹		102,547			127,643			328,657			392,290
Inventory costs		(10,117	)		656,495			(10,007	)		666,246
Shipment and logistics		14,103			23,505			29,983			64,497
Warranty		25,309			33,192			36,684			76,454
Depreciation and amortization		13,849			13,529			42,980			39,111
Directly related overhead costs		15,975			13,248			42,608			40,797
Other²		45,665			309,750			154,521			438,747
Financial (income) expense, net		(3,040	)		(5,558	)		(5,785	)		2,371
Income taxes		2,563			121,108			13,946			85,109
Net loss from equity method investments		376			577			951			1,440
Net loss	$	(50,060	)	$	(1,230,789	)	$	(273,327	)	$	(1,518,918	)

¹Including stock-based compensation expenses.

²Represents indirect costs of goods, consultants and sub-contractors, marketing, bad debt and impairments and dispositions.

The following table presents revenues disaggregated by geographical location:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
United States	$	203,252	$	103,224	$	520,481	$	265,650
Europe		100,463		82,959		218,224		274,433
International markets		36,462		49,252		110,381		165,156
Total revenues	$	340,177	$	235,435	$	849,086	$	705,239

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)

9 Months Ended

Sep. 30, 2025

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of prepaid expenses and other current assets

	September 30, 2025		December 31, 2024
Vendor non-trade receivables¹	$	93,337	$	198,211
Government authorities²		258,093		213,290
Prepayments		36,770		25,291
Asset held for sale		-		60,500
Other		16,199		25,735
Total prepaid expenses and other current assets	$	404,399	$	523,027

OTHER LONG TERM LIABILITIES

9 Months Ended

Sep. 30, 2025

Other Liabilities Disclosure [Abstract]

OTHER LONG TERM LIABILITIES

NOTE 12: OTHER LONG TERM LIABILITIES

	September 30, 2025		December 31, 2024
Tax liabilities	$	10,331	$	-
Accrued severance pay		2,415		6,079
Long term accrued expenses		1,510		-
Other		1,181		2,347
	$	15,437	$	8,426

OTHER LONG TERM ASSETS (Schedule of Other Long Term Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Other Assets, Noncurrent [Abstract]
Cloud computing arrangements	$ 38,764	$ 29,366
Investments in privately held companies	6,375	20,976
Severance pay fund	0	9,185
Prepaid expenses and other	1,214	5,209
Total other long term assets	$ 46,353	$ 64,736

DEFERRED REVENUES AND CUSTOMERS ADVANCES (Schedule of Balances of Deferred Revenues and Customer Advances) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Balance, at the beginning of the period	$ 285,905	$ 251,014	$ 371,919	$ 255,443
Revenue recognized	(25,696)	(17,824)	(137,717)	(37,442)
Increase in deferred revenues and customer advances	62,795	20,947	88,802	36,136
Balance, at the end of the period	323,004	254,137	323,004	254,137
Less current portion	(45,873)	(27,367)	(45,873)	(27,367)
Long term portion	$ 277,131	$ 226,770	$ 277,131	$ 226,770

SEGMENT INFORMATION (Schedule of Revenues Within Geographic Areas) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 340,177	$ 235,435	$ 849,086	$ 705,239
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	203,252	103,224	520,481	265,650
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	100,463	82,959	218,224	274,433
International markets [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 36,462	$ 49,252	$ 110,381	$ 165,156

- Definition

+ References

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

9 Months Ended

Sep. 30, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

NOTE 6: DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

During the nine months ended September 30, 2025, the Company instituted a foreign currency cash flow hedging program to reduce the risk of a forecasted increase in the value of foreign currency cash flows, resulting from payment of salaries in Israeli currency, the New Israeli Shekels (“NIS”). The Company hedges portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.

As of September 30, 2025, the Company entered into forward contracts as well as put and call options to sell U.S. dollars (“USD”) in the amounts of NIS 24 million and NIS 138 million, respectively.

In addition to the above-mentioned cash flow hedge transactions, the Company occasionally enters into derivative instrument arrangements to hedge the Company’s exposure to currencies other than USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the condensed consolidated statement of loss, under “Financial income (expense), net”.

As of September 30, 2025, the Company entered into forward contracts and put and call options to sell Euro (“EUR”) in the amounts of USD 30 million and USD 10 million, respectively.

The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.

The fair values of outstanding derivative instruments were as follows:

	Balance sheet location	September 30, 2025			December 31, 2024
Derivative assets of options and forward contracts:
Designated cash flow hedges	Prepaid expenses and other current assets	$	2,774		$	1,262
Non-designated hedges	Prepaid expenses and other current assets		19			-
Total derivative assets		$	2,793		$	1,262
Derivative liabilities of options and forward contracts:
Non-designated hedges	Accrued expenses and other current liabilities	$	(1,106	)	$	-

Gains (losses) on derivative instruments are summarized below:

		Three Months Ended September 30,				Nine Months Ended September 30,
	Affected line item	2025		2024		2025			2024
Foreign exchange contracts
Non Designated Hedging Instruments	Condensed Consolidated Statements of Loss - Financial income (expense), net	$	564	$	-	$	(3,621	)	$	802
Designated Hedging Instruments	Condensed Consolidated Statements of Comprehensive Loss - Cash flow hedges	$	571	$	1,131	$	6,869		$	(1,426	)

See Note 15 for information regarding gains (losses) from designated hedging instruments reclassified from accumulated other comprehensive loss.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 182
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-182

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 185
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-185

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 184
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-184

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 181
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-181

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4H
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4H
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 15
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480960/815-15-50-3

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 183
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-183

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4I
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4I

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4F
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/815/tableOfContent

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C

+ Details

OTHER OPERATING EXPENSE (INCOME), NET

9 Months Ended

Sep. 30, 2025

Other Income and Expenses [Abstract]

OTHER OPERATING EXPENSE (INCOME), NET

NOTE 16: OTHER OPERATING EXPENSE (INCOME), NET

The following table presents the expenses (income) recorded in the three and nine months ended September 30, 2025, and 2024:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Impairment of asset-held for sale	$	-		$	-		$	37,050		$	-
Loss from business disposition		-			-			17,982			-
Loss (gain) from sale of property, plant and equipment		156			(644	)		(10,075	)		1,838
Impairment of intangible assets and goodwill		-			24,725			-			24,725
Impairment and disposal by abandonment of property, plant and equipment		673			204,888			2,665			206,620
Other		(1,167	)		4,960			(5,811	)		4,088
Total other operating expense (income), net	$	(338	)	$	233,929		$	41,811		$	237,271

OTHER LONG TERM LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2025

Other Liabilities Disclosure [Abstract]

Schedule of other long term liabilities

	September 30, 2025		December 31, 2024
Tax liabilities	$	10,331	$	-
Accrued severance pay		2,415		6,079
Long term accrued expenses		1,510		-
Other		1,181		2,347
	$	15,437	$	8,426

RESTRUCTURING AND OTHER EXIT ACTIVITIES

9 Months Ended

Sep. 30, 2025

Restructuring and Related Activities [Abstract]

RESTRUCTURING AND OTHER EXIT ACTIVITIES

NOTE 17: RESTRUCTURING AND OTHER EXIT ACTIVITIES

On January 21, 2024, the Company announced the adoption of a restructuring plan in response to challenging industry conditions. Under this restructuring plan, the Company reduced its headcount by approximately 900 employees over the first half of 2024 in an involuntary workforce reduction. The adoption of this restructuring plan followed the Company’s previous measures taken to align with current market conditions, including termination of our manufacturing in Mexico and China, and discontinuation of the Company’s light commercial vehicle e-mobility activity. On July 15, 2024, the Company announced additional workforce reductions, resulting in the layoff of 400 employees.

On November 27, 2024, the Company announced the closure of its Energy Storage Division. In connection with the closure, the Company reduced its headcount by approximately 500 employees, primarily in manufacturing positions in South Korea. This closure and associated headcount reduction represented approximately 12% of the Company’s overall employee population, at the time, almost all of whom were dismissed over the first half of 2025 (together with the 2024 workforce reductions, the “Restructuring Plans”). On September 4, 2025, as part of the decision to close its Energy Storage Division, the Company, sold its last battery cell manufacturing facility in South Korea. The Company has determined that the discontinuation of its Energy Storage activity does not represent a strategic shift that will have a major effect on the Company's operations and financial results and therefore it did not meet the criteria for discontinued operations classification.

Restructuring and other exit charges for the three months ended September 30, 2025 and September 30, 2024, by type of cost were as follows:

	Three Months Ended September 30, 2025									Three Months Ended September 30, 2024
	Employee termination costs			Contract termination and other			Total			Employee termination costs		Contract termination and other		Total
Cost of revenues	$	(4	)	$	(14,566	)	$	(14,570	)	$	884	$	326	$	1,210
Research and development		(26	)		-			(26	)		648		-		648
Sales and marketing		114			-			114			468		-		468
General and administrative		133			-			133			172		-		172
Total	$	217		$	(14,566	)	$	(14,349	)	$	2,172	$	326	$	2,498

Restructuring and other exit charges for the nine months ended September 30, 2025, and September 30, 2024, by type of cost were as follows:

	Nine Months Ended September 30, 2025								Nine Months Ended September 30, 2024
	Employee termination costs		Contract termination and other			Total			Employee termination costs		Contract termination and other		Total
Cost of revenues	$	470	$	(14,433	)	$	(13,963	)	$	1,738	$	8,622	$	10,360
Research and development		1,214		-			1,214			3,561		248		3,809
Sales and marketing		982		-			982			1,109		-		1,109
General and administrative		1,710		-			1,710			514		118		632
Other operating expenses		-		(3,137	)		(3,137	)		-		-		-
Total	$	4,376	$	(17,570	)	$	(13,194	)	$	6,922	$	8,988	$	15,910

The Company’s liability balance for the restructuring and other exit charges is as follows:

	Employee termination costs			Contract termination and other
Balance as of December 31, 2024	$	1,073		$	23,933
Charges		4,376			(16,473	)
Cash payments		(5,449	)		(6,315	)
Non-cash utilization and other		-			(1,145	)
Balance as of September 30, 2025	$	-		$	-

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Payables and Accruals [Abstract]
Accrued expenses	$ 184,758	$ 166,699
Government authorities	22,364	51,705
Operating lease liabilities	13,717	11,861
Accrual for sales incentives	23,481	11,671
Provision for legal claims	11,648	350
Other	6,874	3,792
Total accrued expenses and other current liabilities	$ 262,842	$ 246,078

LOSS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2025

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net earnings (loss) per share

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Basic and diluted EPS:
Numerator:
Net loss	$	(50,060	)	$	(1,230,789	)	$	(273,327	)	$	(1,518,918	)
Denominator:
Shares used in computing net loss per share of common stock, basic and diluted		59,278,269			57,029,983			58,659,959			56,952,656
Loss per share:
Basic and Diluted	$	(0.84	)	$	(21.58	)	$	(4.66	)	$	(26.67	)

Schedule of outstanding shares of common stock equivalents were excluded from the calculation due to their antidilutive nature

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Stock-based awards		1,154,437		2,552,867		1,698,622		2,055,632
Notes 2025		1,031,132		-		1,170,898		1,510,363
Notes 2029¹		9,819,347		984,342		9,819,347		392,152
Total shares excluded		12,004,916		3,537,209		12,688,867		3,958,147

GENERAL (Policies)

9 Months Ended

Sep. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation:

Trade receivables

Trade receivables:

The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of trade receivables to present the net amount expected to be collected:

Balance as of January 1, 2025	$	43,038
Increase in provision for expected credit losses		8,671
Recoveries collected		(23,445	)
Amounts written off charged against the allowance		(9,363	)
Foreign currency translation		1,939
Balance as of September 30, 2025	$	20,840

Use of estimates

Use of estimates:

Concentrations of supply risks

Concentrations of supply risks:

As of September 30, 2025 two contract manufacturers jointly accounted for 48.1% of the Company’s total trade payables.

As of December 31, 2024, two contract manufacturers jointly accounted for 43.4% of the Company’s total trade payables.

The Company's own manufacturing facility, Sella 1, located in the North of Israel, is also used in the Company's ongoing operations.

Investment in privately-held companies

f. Investment in privately-held companies:

The Company adjusts the carrying value of its investments to fair value upon observable transactions for identical or similar investments of the same issuer.

All gains and losses, whether due to an impairment or revaluation, on investments in privately-held companies, realized and unrealized, are recognized in other income (expense), net.

New accounting standards updates

New accounting standards updates:

Revision to previously issued financial statements

Revision to previously issued financial statements:

The Company has adjusted the relevant previously reported financial information for such immaterial revision, for the three and nine months ended September 30, 2024, as applicable.

The following table provides a summary of the revisions made to the Company’s condensed consolidated statements of loss, for the periods presented:

	Three Months Ended September 30, 2024									Nine Months Ended September 30, 2024
	As reported			Adjustment			As revised			As reported			Adjustment			As revised
Revenues	$	260,903		$	(25,468	)	$	235,435		$	730,707		$	(25,468	)	$	705,239
Gross loss	$	(702,326	)	$	(25,468	)	$	(727,794	)	$	(739,482	)	$	(25,468	)	$	(764,950	)
Operating loss	$	(1,085,266	)	$	(25,468	)	$	(1,110,734	)	$	(1,419,153	)	$	(25,468	)	$	(1,444,621	)
Net loss	$	(1,205,321	)	$	(25,468	)	$	(1,230,789	)	$	(1,493,450	)	$	(25,468	)	$	(1,518,918	)
EPS	$	(21.13	)	$	(0.45	)	$	(21.58	)	$	(26.22	)	$	(0.45	)	$	(26.67	)

The following table provides a summary of the revisions made to the Company’s condensed consolidated statements of cash flows for the period presented:

	Nine Months Ended September 30, 2024
	As reported			Adjustment			As revised
Cash flows provided by operating activities:
Net loss	$	(1,493,450	)	$	(25,468	)	$	(1,518,918	)
Net cash used in operating activities	$	(325,656	)	$	(25,468	)	$	(351,124	)
Net cash provided by investing activities	$	318,755		$	25,468		$	344,223

The following table provides a summary of the revisions made to the Company’s condensed consolidated statements of stockholders' equity for the period presented:

	As of September 30, 2024
	As reported			Adjustment			As revised
Accumulated deficit	$	(715,284	)	$	(25,468	)	$	(740,752	)
Total stockholders’ equity	$	956,366		$	(25,468	)	$	930,898

- Definition

Disclosure of accounting policy for investment in financial asset.

+ References + Details

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-12

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

+ Details

STOCK CAPITAL

9 Months Ended

Sep. 30, 2025

Share-based Payment Arrangement [Abstract]

STOCK CAPITAL

NOTE 13: STOCK CAPITAL

Common stock rights:

Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes, to share equally, on a per share basis, in bonuses, profits, or distributions out of fund legally available therefor, and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company.

Equity Incentive Plans:

The Company’s Amended and Restated 2015 Global Incentive Plan (the “2015 Plan”) became effective upon the consummation of the Company's IPO. The 2015 Plan provides for the grant of options, restricted stock units (“RSU”), performance stock units (“PSU”), and other stock-based awards to directors, employees, officers, and non-employees of the Company and its subsidiaries. As of September 30, 2025, a total of 26,648,950 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”), an aggregate of 12,318,881 shares are still available for future grants.

Under its 2015 Plan, the Company granted PSU awards to certain employees and officers which vest upon the achievement of certain market conditions subject to their continued employment with the Company.

The market condition for the PSUs is based on either the Company’s share price target or total shareholder return (“TSR”) compared to the TSR of companies listed in the S&P 500 index over a two to three year performance period or the 30-day successive average trading price of the Company’s common stock, and are subject to a three-year vesting period. The Company uses a Monte-Carlo simulation to determine the grant date fair value for these awards, which takes into consideration the market price of a share of the Company’s common stock on the date of grant less the present value of dividends expected during the requisite service period, as well as the possible outcomes pertaining to the TSR market condition. The Company recognizes such compensation expenses on an accelerated vesting method.

The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000. As of September 30, 2025, an aggregate of 8,699,806 options are still available for future grants under the 2015 Plan.

A summary of the activity in stock options and related information is as follows:

	Number of options			Weighted average exercise price		Weighted average remaining contractual term in years		Aggregate intrinsic Value
Outstanding as of December 31, 2024		283,419		$	59.16		3.42	$	17
Exercised		(10,400	)		21.23		-		25
Forfeited or expired		(81,832	)		86.86		-		-
Outstanding as of September 30, 2025		191,187		$	49.37		2.58	$	1,578
Vested and expected to vest as of September 30, 2025		191,187		$	49.37		2.58	$	1,578
Exercisable as of September 30, 2025		191,187		$	49.37		2.58	$	1,578

The intrinsic value is the amount by which the closing price of the Company’s common stock on September 30, 2025, or the price on the day of exercise exceeds the exercise price of the stock options, multiplied by the number of in-the-money options.

A summary of the activity in the RSUs and PSUs and related information is as follows:

	RSU					PSU
	Number of Shares Outstanding			Weighted average grant date fair value		Number of Shares Outstanding			Weighted average grant date fair value
Unvested as of December 31, 2024		3,395,347		$	70.62		334,254		$	67.52
Granted		2,234,425			15.64		769,938			6.39
Vested		(1,009,162	)		79.56		-			-
Forfeited		(755,078	)		67.99		(206,808	)		70.67
Unvested as of September 30, 2025		3,865,532		$	37.02		897,384		$	14.35

Employee Stock Purchase Plan (“ESPP”):

The Company adopted an ESPP effective upon the consummation of the IPO. As of September 30, 2025, a total of 5,125,666 shares were reserved for issuance under this plan.

The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use the lesser of either up to 15% of their salaries or $15,000 per participant, to purchase common stock for every six month plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.

As of September 30, 2025, 2,311,170 shares of common stock have been purchased under the ESPP.

As of September 30, 2025, 2,814,496 shares of common stock were available for future issuance under the ESPP.

In accordance with ASC No. 718, the ESPP is compensatory and, as such, results in recognition of compensation cost.

Stock-based compensation expenses:

The Company recognized stock-based compensation expenses related to all stock-based awards in the consolidated statement of loss for the three and nine months ended September 30, 2025, and 2024, as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Stock-based compensation expenses:
Cost of revenues	$	3,959	$	6,038	$	12,335	$	18,224
Research and development		10,681		17,115		36,448		51,893
Sales and marketing		4,348		6,816		13,432		22,876
General and administrative		2,897		6,672		10,357		19,825
Total stock-based compensation expenses	$	21,885	$	36,641	$	72,572	$	112,818

Stock-based compensation capitalized:
Inventory	$	300	$	722	$	1,379	$	2,387
Other long-term assets		382		508		1,214		1,451
Total stock-based compensation capitalized	$	682	$	1,230	$	2,593	$	3,838

For the three and nine months ended September 30, 2025 and 2024, no amounts of tax benefits were recorded in regard to stock-based compensation.

As of September 30, 2025, there were total unrecognized compensation expenses in the amount of $141,367 related to non-vested equity-based compensation arrangements granted. These expenses are expected to be recognized during the period from October 1, 2025, through September 30, 2029.

GENERAL (Schedule of summary of the revisions made to condensed consolidated statements of stockholders' equity (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Equity, Attributable to Parent [Abstract]
Accumulated deficit	$ (1,301,518)			$ (1,028,191)	$ (740,752)
Total stockholders’ equity	$ 479,760	$ 513,219	$ 594,213	$ 658,342	930,898	$ 2,106,189	$ 2,240,551	$ 2,411,909
As reported
Equity, Attributable to Parent [Abstract]
Accumulated deficit					(715,284)
Total stockholders’ equity					956,366
Adjustment
Equity, Attributable to Parent [Abstract]
Accumulated deficit					(25,468)
Total stockholders’ equity					$ (25,468)

- Definition

Amount of accumulated undistributed earnings (deficit).

+ References + Details

- Definition

Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2

+ Details

MARKETABLE SECURITIES

9 Months Ended

Sep. 30, 2025

Marketable Securities [Abstract]

MARKETABLE SECURITIES

NOTE 2: MARKETABLE SECURITIES

The following is a summary of available-for-sale marketable securities as of September 30, 2025:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Matures within one year:
Corporate bonds	$	46,582	$	264	$	(6	)	$	46,840
U.S. Treasury securities		9,247		-		(5	)		9,242
U.S. Government agency securities		2,971		11		-			2,982
Total	$	58,800	$	275	$	(11	)	$	59,064

The following is a summary of available-for-sale marketable securities as of December 31, 2024:

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Matures within one year:
Corporate bonds	$	290,570	$	97	$	(811	)	$	289,856
U.S. Treasury securities		12,596		-		(2	)		12,594
U.S. Government agency securities		8,810		19		-			8,829
		311,976		116		(813	)		311,279
Matures after one year:
Corporate bonds		36,006		252		(17	)		36,241
U.S. Government agency securities		6,309		47		-			6,356
		42,315		299		(17	)		42,597
Total	$	354,291	$	415	$	(830	)	$	353,876

Proceeds from the sale of available-for-sale marketable securities, during the three and nine months ended September 30, 2025, was $76,288, which did not lead to realized gains or losses.

Proceeds from sales of available-for-sale marketable securities, during the three and nine months ended September 30, 2024, were $18,724 and $70,642, which led to realized gains of $777 and $2,747, respectively.

As of September 30, 2025, and December 31, 2024, the Company did not record an allowance for credit losses for its available-for-sale marketable securities.

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)
$ in Thousands

Sep. 30, 2025

Dec. 31, 2024

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Vendor non-trade receivables

^[1]

$ 93,337

$ 198,211

Government authorities

^[2]

258,093

213,290

Prepayments

36,770

25,291

Assets held for sale

60,500

Other

16,199

25,735

Total prepaid expenses and other current assets

$ 404,399

$ 523,027

[1]	Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products, components and other testing equipment for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.
[2]	Including (1) Advanced Manufacturing Production Tax Credits (“AMPTC”), which incentivize the production of eligible components within the U.S. under IRC Section 45X, (2) income tax receivables and (3) value-added tax receivables from tax authorities.

STOCK CAPITAL (Schedule of Stock-based Compensation Expense for Employees and Nonemployee) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	$ 21,885	$ 36,641	$ 72,572	$ 112,818
Total stock-based compensation capitalized	682	1,230	2,593	3,838
Cost of revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	3,959	6,038	12,335	18,224
Research and development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	10,681	17,115	36,448	51,893
Selling and marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	4,348	6,816	13,432	22,876
General and administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expenses	2,897	6,672	10,357	19,825
Inventory [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation capitalized	300	722	1,379	2,387
Other long-term assets [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation capitalized	$ 382	$ 508	$ 1,214	$ 1,451

FAIR VALUE MEASUREMENTS (Schedule of Assets Measured at Fair Value) (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Level 1 [Member] \| Cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	$ 417,229	$ 239,020
Level 1 [Member] \| Money market mutual funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	21,070	21,075
Level 1 [Member] \| Deposits [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	1,216	14,516
Level 1 [Member] \| Restricted cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	47,481	135,328
Level 2 [Member] \| Derivative instruments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of liabilities	(1,106)	0
Level 2 [Member] \| Derivative instruments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	2,793	1,262
Level 2 [Member] \| Short-term marketable securities: Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	46,840	289,856
Level 2 [Member] \| Short-term marketable securities: U.S. Treasury securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	9,242	12,594
Level 2 [Member] \| Short-term marketable securities: U.S. Government agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	2,982	8,829
Level 2 [Member] \| Long-term marketable securities: Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	0	36,241
Level 2 [Member] \| Long-term marketable securities: U.S. Government agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of assets	$ 0	$ 6,356

ACCUMULATED OTHER COMPREHENSIVE LOSS

9 Months Ended

Sep. 30, 2025

Accumulated Other Comprehensive Income Loss [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

NOTE 15: ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table summarizes the changes in accumulated balances of other comprehensive loss, net of taxes:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Unrealized gains (losses) on available-for-sale marketable securities
Beginning balance	$	207		$	(3,465	)	$	(385	)	$	(4,960	)
Revaluation		50			4,571			642			8,304
Tax on revaluation		-			(1,017	)		-			(1,786	)
Other comprehensive income before reclassifications		50			3,554			642			6,518
Reclassification		2			(777	)		2			(2,747	)
Tax on reclassification		-			198			-			699
Gains reclassified from accumulated other comprehensive income (loss)		2			(579	)		2			(2,048	)
Net current period other comprehensive income		52			2,975			644			4,470
Ending balance	$	259		$	(490	)	$	259		$	(490	)
Unrealized gains (losses) on cash flow hedges
Beginning balance	$	5,371		$	407		$	1,262		$	3,940
Revaluation		1,003			1,286			7,599			(1,620	)
Tax on revaluation		(432	)		(155	)		(730	)		194
Other comprehensive losses (gains) before reclassifications		571			1,131			6,869			(1,426	)
Reclassification		(3,600	)		(646	)		(6,087	)		(1,755	)
Tax on reclassification		432			78			730			211
Gains reclassified from accumulated other comprehensive income (loss)		(3,168	)		(568	)		(5,357	)		(1,544	)
Net current period other comprehensive income (loss)		(2,597	)		563			1,512			(2,970	)
Ending balance	$	2,774		$	970		$	2,774		$	970
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
Beginning balance	$	(77,886	)	$	(64,298	)	$	(78,714	)	$	(43,335	)
Revaluation		(134	)		13,555			694			(7,408	)
Ending balance	$	(78,020	)	$	(50,743	)	$	(78,020	)	$	(50,743	)
Unrealized gains (losses) on foreign currency translation
Beginning balance	$	14,440		$	(10,594	)	$	1,360		$	(2,530	)
Revaluation		(3,497	)		3,604			9,583			(4,460	)
Ending balance	$	10,943		$	(6,990	)	$	10,943		$	(6,990	)
Total	$	(64,044	)	$	(57,253	)	$	(64,044	)	$	(57,253	)

The following table summarizes the reclassification out of “Accumulated other comprehensive loss”, net of taxes:

Details about Accumulated Other Comprehensive Loss Components	Three Months Ended September 30,						Nine Months Ended September 30,						Affected Line Item in the Statement of Loss
	2025			2024			2025			2024
Unrealized gains (losses) on available-for-sale marketable securities
	$	(2	)	$	777		$	(2	)	$	2,747		Financial income (expense), net
		-			(198	)		-			(699	)	Income taxes
	$	(2	)	$	579		$	(2	)	$	2,048		Total, net of income taxes
Unrealized gains (losses) on cash flow hedges, net
		614			78			1,046			204		Cost of revenues
		1,937			369			3,231			1,031		Research and development
		474			85			791			231		Sales and marketing
		575			114			1,019			289		General and administrative
	$	3,600		$	646		$	6,087		$	1,755		Total, before income taxes
		(432	)		(78	)		(730	)		(211	)	Income taxes
		3,168			568			5,357			1,544		Total, net of income taxes
Total reclassifications for the period	$	3,166		$	1,147		$	5,355		$	3,592

CONVERTIBLE SENIOR NOTES (Tables)

9 Months Ended

Sep. 30, 2025

Debt Disclosure [Abstract]

Schedule of convertible senior notes

	September 30, 2025			December 31, 2024
Notes 2025
Principal	$	-		$	347,500
Unamortized issuance costs		-			(1,195	)
Net carrying amount Notes 2025		-			346,305
Notes 2029
Principal		337,000			337,000
Unamortized issuance costs		(5,831	)		(6,994	)
Net carrying amount Notes 2029		331,169			330,006

Total notes carrying amount	$	331,169		$	676,311

Schedule of costs related to Notes

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Notes 2025
Debt issuance cost	$	383	$	1,138	$	1,183	$	1,874
Notes 2029
Debt issuance cost	$	392	$	393	$	1,163	$	400
Contractual interest expense	$	1,896	$	1,913	$	5,687	$	1,950

PREPAID EXPENSES AND OTHER CURRENT ASSETS

9 Months Ended

Sep. 30, 2025

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

PREPAID EXPENSES AND OTHER CURRENT ASSETS

NOTE 4: PREPAID EXPENSES AND OTHER CURRENT ASSETS

	September 30, 2025		December 31, 2024
Vendor non-trade receivables¹	$	93,337	$	198,211
Government authorities²		258,093		213,290
Prepayments		36,770		25,291
Asset held for sale		-		60,500
Other		16,199		25,735
Total prepaid expenses and other current assets	$	404,399	$	523,027

¹Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products, components and other testing equipment for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.

²Including (1) Advanced Manufacturing Production Tax Credits (“AMPTC”), which incentivize the production of eligible components within the U.S. under IRC Section 45X, (2) income tax receivables and (3) value-added tax receivables from tax authorities.

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2025

Payables and Accruals [Abstract]

Schedule of accrued expenses and other current liabilities

	September 30, 2025		December 31, 2024
Accrued expenses	$	184,758	$	166,699
Government authorities		22,364		51,705
Operating lease liabilities		13,717		11,861
Accrual for sales incentives		23,481		11,671
Provision for legal claims		11,648		350
Other		6,874		3,792
Total accrued expenses and other current liabilities	$	262,842	$	246,078

GENERAL (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended		12 Months Ended
GENERAL (Narrative) (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Organization Consolidation and Presentation of Financial Statements [Line Items]
Impairment of investment in Ampeers Energy GmbH ("Ampeers")	$ 15,057	$ 15,057	$ 5,000
Accounts payable [Member] \| Supplier concentration risk [Member]
Organization Consolidation and Presentation of Financial Statements [Line Items]
Concentration risk percentage		48.10%		43.40%

CONVERTIBLE SENIOR NOTES (Schedule of Convertible Senior Notes) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Liability Abstract
Convertible Debt, Current	$ 0		$ 0		$ 346,305
Convertible senior notes, net	331,169		331,169		330,006
Notes 2025 [Member]
Liability Abstract
Principal	0		0		347,500
Unamortized issuance costs	0		0		(1,195)
Convertible Debt, Current	0		0		346,305
Debt issuance cost	383	$ 1,138	1,183	$ 1,874
Notes 2029 [Member]
Liability Abstract
Principal	337,000		337,000		337,000
Unamortized issuance costs	(5,831)		(5,831)		(6,994)
Convertible senior notes, net	331,169		331,169		330,006
Debt issuance cost	392	393	1,163	400
Contractual interest expense	1,896	$ 1,913	5,687	$ 1,950
Convertible Senior Notes [Member]
Liability Abstract
Convertible Debt	$ 331,169		$ 331,169		$ 676,311

ACCUMULATED OTHER COMPREHENSIVE LOSS (Schedule of Reclassifications of Other Comprehensive Income Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenues	$ 268,034	$ 963,229	$ 727,276	$ 1,470,189
Research and development	54,146	70,372	169,529	214,999
Sales and marketing	26,911	37,427	87,293	116,316
General and administrative	26,574	41,212	76,546	111,085
Total, before income taxes	(47,121)	(1,109,104)	(258,430)	(1,432,369)
Income taxes	2,563	121,108	13,946	85,109
Total, net of income taxes	(50,060)	(1,230,789)	(273,327)	(1,518,918)
Total reclassifications for the period[Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Total reclassifications for the period	3,166	1,147	5,355	3,592
Unrealized gains (losses) on available-for-sale marketable securities [Member] \| Total reclassifications for the period[Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Financial income (expense), net	(2)	777	(2)	2,747
Income taxes	0	(198)	0	(699)
Total, net of income taxes	(2)	579	(2)	2,048
Unrealized gains (losses) on cash flow hedges, net [Member] \| Total reclassifications for the period[Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenues	614	78	1,046	204
Research and development	1,937	369	3,231	1,031
Sales and marketing	474	85	791	231
General and administrative	575	114	1,019	289
Total, before income taxes	3,600	646	6,087	1,755
Income taxes	(432)	(78)	(730)	(211)
Total, net of income taxes	$ 3,168	$ 568	$ 5,357	$ 1,544

DEFERRED REVENUES AND CUSTOMERS ADVANCES (Tables)

9 Months Ended

Sep. 30, 2025

Revenue Recognition and Deferred Revenue [Abstract]

Schedule of balances of deferred revenues

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Balance, at the beginning of the period	$	285,905		$	251,014		$	371,919		$	255,443
Revenue recognized		(25,696	)		(17,824	)		(137,717	)		(37,442	)
Increase in deferred revenues and customer advances		62,795			20,947			88,802			36,136
Balance, at the end of the period		323,004			254,137			323,004			254,137
Less current portion		(45,873	)		(27,367	)		(45,873	)		(27,367	)
Long term portion	$	277,131		$	226,770		$	277,131		$	226,770

Schedule estimated revenues expected to recognized in future to performance obligations

2025	$	27,141
2026		22,673
2027		13,962
2028		23,848
2029		23,728
Thereafter		211,652
Total deferred revenues	$	323,004

OTHER OPERATING EXPENSE (INCOME), NET (Tables)

9 Months Ended

Sep. 30, 2025

Other Income and Expenses [Abstract]

Schedule of other operating expense (income), net

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Impairment of asset-held for sale	$	-		$	-		$	37,050		$	-
Loss from business disposition		-			-			17,982			-
Loss (gain) from sale of property, plant and equipment		156			(644	)		(10,075	)		1,838
Impairment of intangible assets and goodwill		-			24,725			-			24,725
Impairment and disposal by abandonment of property, plant and equipment		673			204,888			2,665			206,620
Other		(1,167	)		4,960			(5,811	)		4,088
Total other operating expense (income), net	$	(338	)	$	233,929		$	41,811		$	237,271

MARKETABLE SECURITIES (Schedule of AFS Marketable Debt Securities) (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Marketable Securities [Line Items]
Available-for-sale - matures within one year, Amortized cost		$ 311,976
Available-for-sale - matures within one year, Gross unrealized gains		116
Available-for-sale - matures within one year, Gross unrealized losses		(813)
Available for-sale - matures within one year, fair value		311,279
Available for-sale - matures after one year, amortized cost		42,315
Available-for-sale - matures after one year, Gross unrealized gains		299
Available-for-sale - matures after one year, Gross unrealized losses		(17)
Available for-sale - matures after one year, fair value		42,597
Amortized cost	$ 58,800	354,291
Gross unrealized gains	275	415
Gross unrealized losses	(11)	(830)
Fair value	59,064	353,876
Corporate bonds [Member]
Marketable Securities [Line Items]
Available-for-sale - matures within one year, Amortized cost	46,582	290,570
Available-for-sale - matures within one year, Gross unrealized gains	264	97
Available-for-sale - matures within one year, Gross unrealized losses	(6)	(811)
Available for-sale - matures within one year, fair value	46,840	289,856
Available for-sale - matures after one year, amortized cost		36,006
Available-for-sale - matures after one year, Gross unrealized gains		252
Available-for-sale - matures after one year, Gross unrealized losses		(17)
Available for-sale - matures after one year, fair value		36,241
U.S. Treasury securities [Member]
Marketable Securities [Line Items]
Available-for-sale - matures within one year, Amortized cost	9,247	12,596
Available-for-sale - matures within one year, Gross unrealized gains	0	0
Available-for-sale - matures within one year, Gross unrealized losses	(5)	(2)
Available for-sale - matures within one year, fair value	9,242	12,594
U.S. Government agency securities [Member]
Marketable Securities [Line Items]
Available-for-sale - matures within one year, Amortized cost	2,971	8,810
Available-for-sale - matures within one year, Gross unrealized gains	11	19
Available-for-sale - matures within one year, Gross unrealized losses	0	0
Available for-sale - matures within one year, fair value	$ 2,982	8,829
Available for-sale - matures after one year, amortized cost		6,309
Available-for-sale - matures after one year, Gross unrealized gains		47
Available-for-sale - matures after one year, Gross unrealized losses		0
Available for-sale - matures after one year, fair value		$ 6,356

WARRANTY OBLIGATIONS (Schedule of Product Warranty Obligations) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Changes in the Company's product warranty liability
Balance, at the beginning of the period	$ 397,564	$ 490,832	$ 432,365	$ 518,244
Accruals for warranty during the period	20,177	15,981	54,271	47,320
Changes in estimates	4,143	6,878	(557)	16,188
Settlements	(27,040)	(34,787)	(91,235)	(102,848)
Balance, at end of the period	394,844	478,904	394,844	478,904
Less current portion	(111,738)	(163,561)	(111,738)	(163,561)	$ (140,249)
Long term portion	$ 283,106	$ 315,343	$ 283,106	$ 315,343	$ 292,116

SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Reportable Segments and Operating Income

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Revenues	$	340,177		$	235,435		$	849,086		$	705,239
Less:
Direct costs of goods		183,007			172,735			487,875			417,095
Salaries¹		102,547			127,643			328,657			392,290
Inventory costs		(10,117	)		656,495			(10,007	)		666,246
Shipment and logistics		14,103			23,505			29,983			64,497
Warranty		25,309			33,192			36,684			76,454
Depreciation and amortization		13,849			13,529			42,980			39,111
Directly related overhead costs		15,975			13,248			42,608			40,797
Other²		45,665			309,750			154,521			438,747
Financial (income) expense, net		(3,040	)		(5,558	)		(5,785	)		2,371
Income taxes		2,563			121,108			13,946			85,109
Net loss from equity method investments		376			577			951			1,440
Net loss	$	(50,060	)	$	(1,230,789	)	$	(273,327	)	$	(1,518,918	)

¹Including stock-based compensation expenses.

²Represents indirect costs of goods, consultants and sub-contractors, marketing, bad debt and impairments and dispositions.

Schedule of Revenues By Product Family

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
United States	$	203,252	$	103,224	$	520,481	$	265,650
Europe		100,463		82,959		218,224		274,433
International markets		36,462		49,252		110,381		165,156
Total revenues	$	340,177	$	235,435	$	849,086	$	705,239

CONVERTIBLE SENIOR NOTES

9 Months Ended

Sep. 30, 2025

Debt Disclosure [Abstract]

CONVERTIBLE SENIOR NOTES

NOTE 11: CONVERTIBLE SENIOR NOTES

On September 25, 2020, the Company sold an aggregate principal amount of $632,500 of its 0.00% convertible senior notes, due 2025 (the “Notes 2025”). The Notes 2025 were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes 2025 did not bear regular interest and matured on September 15, 2025. The Notes 2025 were general senior unsecured obligations of the Company. The initial conversion rate for the Notes 2025 was 3.5997 shares of common stock per $1,000 principal amount of Notes 2025, which was equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture. In March 2025 the Company repurchased $5,250 principal amount of its Notes 2025. The Company recorded a net gain of $146, under other income, net, from the repurchase. The Company settled all of its remaining Notes 2025 on September 15, 2025. As part of the settlement, the Company paid $342,250 in cash towards principal amount of the Notes 2025 and no shares were issued in connection with the settlement as the conversion value was less than the principal amount of the Notes 2025. Following the settlement, there were no Notes 2025 outstanding as of September 30, 2025.

On June 28, 2024, the Company sold an aggregate principal amount of $300,000 of its 2.25% convertible senior notes, due in 2029 (the “Notes 2029”). The Notes 2029 were sold pursuant to an indenture, dated June 28, 2024 (the “Indenture 2029”), between the Company and U.S. Bank National Association, as trustee. The Notes 2029 will bear interest at a rate of 2.25% per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2025. The Notes 2029 mature on July 1, 2029, unless repurchased, redeemed or converted in accordance with their terms prior to such date. The Notes 2029 are general senior unsecured obligations of the Company. Holders may convert their Notes 2029 at any time prior to the close of business on the business day immediately preceding April 1, 2029 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2024 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes 2029 for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events or if the Company provides a notice of redemption as described in the Indenture 2029. In addition, holders may convert their Notes 2029, in multiples of $1,000 principal amount, at their option at any time beginning on or after April 1, 2029, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes 2029, without regard to the foregoing circumstances. The initial conversion rate for the Notes 2029 is 29.1375 shares of common stock per $1,000 principal amount of Notes 2029, which is equivalent to an initial conversion price of approximately $34.32 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture 2029.

Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock.

In addition, upon the occurrence of a fundamental change (as defined in the Indenture 2029), holders of the Notes 2029 may require the Company to repurchase all or a portion of their Notes 2029, in multiples of $1,000 principal amounts, at a repurchase price of 100% of the principal amount of the Notes 2029, plus any accrued and unpaid interest, if any, up to, but not including, the repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes 2029 may be increased.

The Notes 2029 are not redeemable prior to July 6, 2027. On or after July 6, 2027, the Company may redeem the Notes 2029 at its option if the last reported sale price of the common stock has been at least 130% of the conversion price, then in effect, for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on and including the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Notes 2029 to be redeemed, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date.

The net proceeds from the offering of the Notes 2029 were approximately $293,200, after deducting fees and estimated expenses. Congruently, the Company has entered into capped call transactions (as detailed below). The Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. The Company also used approximately $267,900 of the net proceeds, from this offering, to repurchase $285,000 principal amount of its Notes 2025. In June 2024, the Company recorded under other income a gain of $15,456 from the repurchase of Notes 2025.

The Company accounts for the Notes 2029 at amortized cost, as a single unit of account on the balance sheet. The carrying value of the liability is represented by the face amount of the Notes 2029, less debt issuance costs, adjusted for any amortization of issuance costs. Issuance costs are being amortized as interest expense over the term of the Notes 2029, using the effective interest rate method.

The capped call transactions are expected generally to reduce the potential dilution to the common stock upon any conversion of the Notes 2029 and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes 2029, as the case may be, in the event that the market price per share of common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions. The strike price initially corresponds to the conversion price of the Notes and is subject to customary anti-dilution adjustments. If, however, the market price per share of common stock exceeds $48.84, the initial cap price of the capped call transactions, there would nevertheless be unmitigated dilution and/or no offset of any cash payments, in each case, attributable to the amount by which the market price of the common stock exceeds the cap price. The cap price is subject to certain customary adjustments under the terms of the capped call transactions.

The capped call transactions are considered a freestanding instrument as they were entered into separately and apart from Notes 2029. In addition, the conversion or redemption of the Notes 2029 would not automatically result in the exercise of the capped call.

As the capped call transactions are indexed to the Company's common stock, they were recorded as a reduction of additional paid-in capital in the condensed consolidated balance sheets.

On July 8, 2024 the Company sold to Goldman Sachs & Co. LLC, as representative of the several initial purchasers (the “Initial Purchasers”), and the Initial Purchasers purchased from the Company, $37,000 aggregate principal amount of additional Notes 2029. The additional Notes 2029 were sold pursuant to the Initial Purchasers’ exercise of the option granted by the Company to the Initial Purchasers to purchase additional Notes 2029, solely to cover over-allotments, under the purchase agreement described in the Company's Form 8-K filed on June 28, 2024.

The net proceeds from the exercise of the option granted by the Company to the Initial Purchasers of the Notes 2029 were approximately $36,237, after deducting fees and estimated expenses. Congruently, the Company has entered into additional capped call transactions. The Company used approximately $3,111 of the net proceeds from this offering to pay the cost of the additional capped call transactions. The Company intends to use the remainder of the net proceeds from the offering for general corporate purposes.

The convertible senior notes consisted of the following as of September 30, 2025 and December 31, 2024:

	September 30, 2025			December 31, 2024
Notes 2025
Principal	$	-		$	347,500
Unamortized issuance costs		-			(1,195	)
Net carrying amount Notes 2025		-			346,305
Notes 2029
Principal		337,000			337,000
Unamortized issuance costs		(5,831	)		(6,994	)
Net carrying amount Notes 2029		331,169			330,006

Total notes carrying amount	$	331,169		$	676,311

Costs related to the Notes 2025 and the Notes 2029 for the three and nine months ended September 30, 2025 and September 30, 2024 were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Notes 2025
Debt issuance cost	$	383	$	1,138	$	1,183	$	1,874
Notes 2029
Debt issuance cost	$	392	$	393	$	1,163	$	400
Contractual interest expense	$	1,896	$	1,913	$	5,687	$	1,950

As of September 30, 2025, the unamortized issuance costs of the Notes 2029 will be amortized over the remaining term of approximately 3.8 years.

The annual effective interest rates of the Notes 2029 is 2.75%.

As of September 30, 2025, the estimated fair value of the Notes 2029, which the Company has classified as Level 2 financial instruments, is $460,848. The estimated fair value was determined based on the quoted bid price of the Notes 2029 in an over-the-counter market on the last trading day of the reporting period.

As of September 30, 2025, the if-converted value of the Notes 2029 exceeded the principal amount by $26,316.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Statement of Comprehensive Income [Abstract]
Net loss	$ (50,060)	$ (1,230,789)	$ (273,327)	$ (1,518,918)
Other comprehensive income (loss), net of tax:
Available-for-sale marketable securities	52	2,975	644	4,470
Cash flow hedges	(2,597)	563	1,512	(2,970)
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature	(134)	13,555	694	(7,408)
Foreign currency translation adjustments	(3,497)	3,604	9,583	(4,460)
Total other comprehensive income (loss), net of tax:	(6,176)	20,697	12,433	(10,368)
Comprehensive loss	$ (56,236)	$ (1,210,092)	$ (260,894)	$ (1,529,286)

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References + Details

MARKETABLE SECURITIES (Tables)

9 Months Ended

Sep. 30, 2025

Marketable Securities [Abstract]

Schedule of available-for-sale marketable securities

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Matures within one year:
Corporate bonds	$	46,582	$	264	$	(6	)	$	46,840
U.S. Treasury securities		9,247		-		(5	)		9,242
U.S. Government agency securities		2,971		11		-			2,982
Total	$	58,800	$	275	$	(11	)	$	59,064

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Fair value
Matures within one year:
Corporate bonds	$	290,570	$	97	$	(811	)	$	289,856
U.S. Treasury securities		12,596		-		(2	)		12,594
U.S. Government agency securities		8,810		19		-			8,829
		311,976		116		(813	)		311,279
Matures after one year:
Corporate bonds		36,006		252		(17	)		36,241
U.S. Government agency securities		6,309		47		-			6,356
		42,315		299		(17	)		42,597
Total	$	354,291	$	415	$	(830	)	$	353,876

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical)	3 Months Ended
	Jun. 30, 2025 shares
Statement of Stockholders' Equity [Abstract]
Number of shares transferred from treasury stock	512,858

DEFERRED REVENUES AND CUSTOMERS ADVANCES

9 Months Ended

Sep. 30, 2025

Revenue Recognition and Deferred Revenue [Abstract]

DEFERRED REVENUES AND CUSTOMERS ADVANCES

NOTE 9: DEFERRED REVENUES AND CUSTOMERS ADVANCES

Deferred revenues consist of deferred cloud-based monitoring services, communication services, warranty extension services and advance payments received from customers for the Company’s products. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.

Changes in the balances of deferred revenues and customer advances during the period are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2025			2024			2025			2024
Balance, at the beginning of the period	$	285,905		$	251,014		$	371,919		$	255,443
Revenue recognized		(25,696	)		(17,824	)		(137,717	)		(37,442	)
Increase in deferred revenues and customer advances		62,795			20,947			88,802			36,136
Balance, at the end of the period		323,004			254,137			323,004			254,137
Less current portion		(45,873	)		(27,367	)		(45,873	)		(27,367	)
Long term portion	$	277,131		$	226,770		$	277,131		$	226,770

The following table includes estimated revenues that the Company expects to be recognized in the future, related to performance obligations that are unsatisfied (or partially unsatisfied) as of September 30, 2025:

2025	$	27,141
2026		22,673
2027		13,962
2028		23,848
2029		23,728
Thereafter		211,652
Total deferred revenues	$	323,004

STOCK CAPITAL (Schedule of RSUs and PSUs Activity) (Details)	9 Months Ended
	Sep. 30, 2025 $ / shares shares
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at beginning of period \| shares	3,395,347
Granted \| shares	2,234,425
Vested \| shares	(1,009,162)
Forfeited \| shares	(755,078)
Unvested at end of period \| shares	3,865,532
Weighted average grant date fair value, beginning of period \| $ / shares	$ 70.62
Weighted average grant date fair value, granted \| $ / shares	15.64
Weighted average grant date fair value, vested \| $ / shares	79.56
Weighted average grant date fair value, forfeited \| $ / shares	67.99
Weighted average grant date fair value, end of period \| $ / shares	$ 37.02
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested at beginning of period \| shares	334,254
Granted \| shares	769,938
Vested \| shares	0
Forfeited \| shares	(206,808)
Unvested at end of period \| shares	897,384
Weighted average grant date fair value, beginning of period \| $ / shares	$ 67.52
Weighted average grant date fair value, granted \| $ / shares	6.39
Weighted average grant date fair value, vested \| $ / shares	0
Weighted average grant date fair value, forfeited \| $ / shares	70.67
Weighted average grant date fair value, end of period \| $ / shares	$ 14.35

INCOME TAXES (Narrative) (Details)	3 Months Ended		9 Months Ended
INCOME TAXES (Narrative) (Details)	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Tax Contingency [Line Items]
Corporate tax rate (as a percent)	5.40%	10.90%	5.40%	5.90%

STOCK CAPITAL (Schedule of the Activity in the Share Options) (Details) - Share-Based Payment Arrangement, Option [Member] - Employees and Members of Board of Directors [Member] $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2025 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares
Number of options
Outstanding at the beginning of the period \| shares	283,419
Exercised \| shares	(10,400)
Forfeited or expired \| shares	(81,832)
Outstanding at the end of the period \| shares	191,187	283,419
Weighted average exercise price
Outstanding at the beginning of the period \| $ / shares	$ 59.16
Exercised \| $ / shares	21.23
Forfeited or expired \| $ / shares	86.86
Outstanding at the end of the period \| $ / shares	$ 49.37	$ 59.16
Weighted average remaining contractual term in years
Outstanding	2 years 6 months 29 days	3 years 5 months 1 day
Aggregate Intrinsic Value
Outstanding \| $	$ 1,578	$ 17
Exercised \| $	$ 25
Vested and expected to vest at the end of the period
Number of options \| shares	191,187
Weighted average exercise price \| $ / shares	$ 49.37
Weighted average remaining contractual term in years	2 years 6 months 29 days
Aggregate intrinsic Value \| $	$ 1,578
Exercisable at the end of the period
Number of options \| shares	191,187
Weighted average exercise price \| $ / shares	$ 49.37
Weighted average remaining contractual terms in years	2 years 6 months 29 days
Aggregate intrinsic Value \| $	$ 1,578

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Narrative) (Details) - Sep. 30, 2025 - Foreign exchange forward contracts [Member] ₪ in Millions, $ in Millions	ILS (₪)	USD ($)
Put option [Member]
Derivative [Line Items]
Forward/option contracts	₪ 24	$ 30
Call option [Member]
Derivative [Line Items]
Forward/option contracts	₪ 138	$ 10

LOSS PER SHARE (Schedule of Outstanding Shares of Common Stock Equivalents were Excluded from the Calculation due to their Antidilutive Nature) (Details) - shares

3 Months Ended

9 Months Ended

Sep. 30, 2025

Sep. 30, 2024

Sep. 30, 2025

Sep. 30, 2024

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Total shares excluded

12,004,916

3,537,209

12,688,867

3,958,147

Stock-based awards [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Total shares excluded

1,154,437

2,552,867

1,698,622

2,055,632

Notes 2025 [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Total shares excluded

1,031,132

1,170,898

1,510,363

Notes 2029 [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Total shares excluded

^[1]

9,819,347

984,342

9,819,347

392,152

[1]

n conjunction with the issuance of the Notes 2029 in June 2024, the Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. In July 2024, following an additional issuance of the Notes 2029, $3,111 of net proceeds were used to pay the cost of capped call transactions. In accordance with FASB ASC 260, antidilutive contracts, such as purchased call options are excluded from the computation of diluted net income (loss) per share. Accordingly, any potential impact resulting from capped call transaction is excluded from the Company's computation of diluted net income (loss) per share.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023
Statement of Cash Flows [Abstract]
Cash and cash equivalents	$ 439,515	$ 274,611	$ 303,904
Restricted cash	47,481	135,328	0
Cash, cash equivalents and restricted cash, end of period	$ 486,996	$ 409,939	$ 303,904	$ 338,468

CONVERTIBLE SENIOR NOTES (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended				9 Months Ended
	Jul. 08, 2024	Mar. 31, 2025	Jun. 30, 2024	Jun. 28, 2024	Sep. 25, 2020	Sep. 30, 2025	Sep. 15, 2025
Convertible Senior Notes due 2025 [Member]
Debt Instrument [Line Items]
Debt conversion description				On June 28, 2024, the Company sold an aggregate principal amount of $300,000 of its 2.25% convertible senior notes, due in 2029 (the “Notes 2029”). The Notes 2029 were sold pursuant to an indenture, dated June 28, 2024 (the “Indenture 2029”), between the Company and U.S. Bank National Association, as trustee. The Notes 2029 will bear interest at a rate of 2.25% per year, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2025. The Notes 2029 mature on July 1, 2029, unless repurchased, redeemed or converted in accordance with their terms prior to such date. The Notes 2029 are general senior unsecured obligations of the Company. Holders may convert their Notes 2029 at any time prior to the close of business on the business day immediately preceding April 1, 2029 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2024 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes 2029 for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events or if the Company provides a notice of redemption as described in the Indenture 2029. In addition, holders may convert their Notes 2029, in multiples of $1,000 principal amount, at their option at any time beginning on or after April 1, 2029, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes 2029, without regard to the foregoing circumstances. The initial conversion rate for the Notes 2029 is 29.1375 shares of common stock per $1,000 principal amount of Notes 2029, which is equivalent to an initial conversion price of approximately $34.32 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture 2029.	On September 25, 2020, the Company sold an aggregate principal amount of $632,500 of its 0.00% convertible senior notes, due 2025 (the “Notes 2025”). The Notes 2025 were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes 2025 did not bear regular interest and matured on September 15, 2025. The Notes 2025 were general senior unsecured obligations of the Company. The initial conversion rate for the Notes 2025 was 3.5997 shares of common stock per $1,000 principal amount of Notes 2025, which was equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture. In March 2025 the Company repurchased $5,250 principal amount of its Notes 2025. The Company recorded a net gain of $146, under other income, net, from the repurchase. The Company settled all of its remaining Notes 2025 on September 15, 2025. As part of the settlement, the Company paid $342,250 in cash towards principal amount of the Notes 2025 and no shares were issued in connection with the settlement as the conversion value was less than the principal amount of the Notes 2025. Following the settlement, there were no Notes 2025 outstanding as of September 30, 2025.	The Notes 2029 are not redeemable prior to July 6, 2027. On or after July 6, 2027, the Company may redeem the Notes 2029 at its option if the last reported sale price of the common stock has been at least 130% of the conversion price, then in effect, for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on and including the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Notes 2029 to be redeemed, plus accrued and unpaid interest, if any, up to, but excluding, the redemption date.
Principal amount sold				$ 300,000	$ 632,500
Effective coupon rate				2.25%	0.00%
Maturity date				Jul. 01, 2029	Sep. 15, 2025
Conversion amount				$ 1,000		$ 285,000
Number of shares of common stock per $1,000 principal amount of Notes converted				29.1375	3.5997
Amount of conversion				$ 1,000	$ 1,000
Conversion price				$ 34.32	$ 277.8
Net proceeds of convertible debt						293,200
Net proceeds from offering						25,230
Net proceeds from offering to repurchase						$ 267,900
Other income a gain			$ 15,456
Principal amount of Notes repurchased		$ 5,250
Gain on repurchase of debt Instrument		$ 146
Convertible Debt							$ 342,250
Convertible Senior Notes due 2029 [Member]
Debt Instrument [Line Items]
Principal amount sold	$ 37,000
Net proceeds of convertible debt	36,237
Net proceeds from offering	$ 3,111
Market price per share of common stock exceeding initial cap price						$ 48.84
Amortized period						3 years 9 months 18 days
Effective interest						2.75%
Estimated fair value of notes						$ 26,316
Convertible Senior Notes due 2029 [Member] \| Level 2 [Member]
Debt Instrument [Line Items]
Estimated fair value of notes						$ 460,848

OTHER LONG TERM ASSETS (Tables)

9 Months Ended

Sep. 30, 2025

Other Assets, Noncurrent [Abstract]

Schedule of other long term assets

	September 30, 2025		December 31, 2024
Cloud computing arrangements	$	38,764	$	29,366
Investments in privately held companies		6,375		20,976
Severance pay fund		-		9,185
Prepaid expenses and other		1,214		5,209
Total other long term assets	$	46,353	$	64,736

CONDENSED CONSOLIDATED STATEMENTS OF LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenues	$ 340,177	$ 235,435	$ 849,086	$ 705,239
Cost of revenues	268,034	963,229	727,276	1,470,189
Gross profit (loss)	72,143	(727,794)	121,810	(764,950)
Operating expenses:
Research and development	54,146	70,372	169,529	214,999
Sales and marketing	26,911	37,427	87,293	116,316
General and administrative	26,574	41,212	76,546	111,085
Other operating expense (income), net	(338)	233,929	41,811	237,271
Total operating expenses	107,293	382,940	375,179	679,671
Operating loss	(35,150)	(1,110,734)	(253,369)	(1,444,621)
Financial income (expense), net	3,040	5,558	5,785	(2,371)
Other income (expense), net	(15,011)	(3,928)	(10,846)	14,623
Loss before income taxes	(47,121)	(1,109,104)	(258,430)	(1,432,369)
Income taxes	(2,563)	(121,108)	(13,946)	(85,109)
Net loss from equity method investments	(376)	(577)	(951)	(1,440)
Net loss	$ (50,060)	$ (1,230,789)	$ (273,327)	$ (1,518,918)
Net basic loss per share of common stock	$ (0.84)	$ (21.58)	$ (4.66)	$ (26.67)
Net diluted loss per share of common stock	$ (0.84)	$ (21.58)	$ (4.66)	$ (26.67)
Weighted average number of shares used in computing net basic loss per share of common stock	59,278,269	57,029,983	58,659,959	56,952,656
Weighted average number of shares used in computing net diluted loss per share of common stock	59,278,269	57,029,983	58,659,959	56,952,656

COMMITMENTS AND CONTINGENT LIABILITIES

9 Months Ended

Sep. 30, 2025

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 14: COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees:

As of September 30, 2025, contingent liabilities exist regarding guarantees in the amounts of $43,455, $4,564 and $1,522, for each of securing projects with customers and vendors, office rent lease agreements, and other transactions, respectively.

Contractual purchase obligations:

The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.

As of September 30, 2025, the Company had non-cancellable purchase obligations totaling approximately $530,674, out of which the Company recorded a provision for loss in the amount of $25,493.

As of September 30, 2025, the Company had contractual obligations for capital expenditures totaling approximately $26,513. These commitments reflect purchases of automated assembly lines and other machinery related to the Company’s general manufacturing process and are primarily for its new manufacturing sites in the U.S.

Legal claims:

From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.

As of September 30, 2025, the Company recorded an accrual of $11,648 for legal claims which was recorded under accrued expenses and other current liabilities.

On November 3, 2023, Daphne Shen, a purported stockholder of the Company, filed a proposed class action complaint for violation of federal securities laws, individually and putatively on behalf of all others similarly situated, in the U.S. District Court of the Southern District of New York against the Company, the Company’s former CEO and the Company’s former CFO. The complaint alleges violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants. The complaint seeks class certification, damages, interest, attorneys’ fees, and other relief. On December 13, 2023, Javier Cascallar filed a similar proposed class action. On January 2, 2024, six purported lead plaintiffs filed motions in the Shen litigation seeking to consolidate the Cascallar and Shen litigations and appoint lead plaintiffs and lead counsel pursuant to the procedures of the Private Securities Litigation Reform Act of 1995.

On February 7, 2024, the Court consolidated the two actions (the “Consolidated Securities Litigation”), and appointed co-lead plaintiffs (the “Plaintiffs”) and lead counsel. On April 22, 2024, the co-lead Plaintiffs filed an amended complaint adding two additional officers. The amended complaint made substantially similar allegations and claims. Defendants moved to dismiss the amended complaint on July 15, 2024. On December 4, 2024, the Court issued an order granting in part the motion, dismissing all allegations except those relating to two purported misstatements. The Court allowed the Plaintiffs to again amend their complaint, and they filed a second amended complaint (the “Second Amended Complaint”) on January 3, 2025. On February 10, 2025, Defendants moved to dismiss the Second Amended Complaint. On April 7, 2025, the Court issued an order granted in part the motion, dismissing all allegations except those related to alleged misstatements characterizing inventory levels as “low” and those relating to demand in Europe. Discovery is ongoing.

Plaintiffs filed a motion for class certification on October 17, 2025. Defendants’ deadline to file an opposition to Plaintiffs’ motion is January 16, 2025.

On March 15, 2024, Abdul Hirani filed a purported derivative complaint (the “Hirani Complaint”) in the U.S. District Court for the Southern District of New York against certain current and former SolarEdge executive officers and board members, including Zvi Lando, Ronen Faier, Nadav Zafrir, Betsy Atkins, Marcel Gani, Dana Gross, Dirk Hoke, Avery More, and Tal Payne. The Hirani Complaint makes largely the same allegations as those in the Consolidated Securities Litigation, namely, that the Company failed to disclose information about SolarEdge’s inventory in Europe and cancellation rates from European distributors, which allegedly resulted in material misstatements about the Company’s business and prospects in its quarterly filings. The Hirani Complaint contends that defendants’ role in allowing those alleged misstatements to be made constitutes (i) breach of fiduciary duty, (ii) aiding and abetting breach of fiduciary duty, (iii) unjust enrichment, (iv) waste of corporate assets, and (v) securities fraud under Section 10(b) of the Exchange Act. The complaint seeks compensatory and punitive damages, interest, attorneys’ fees, and other relief.

On June 10, 2024, Jonathan Blaufarb filed a second purported derivative complaint (the “Blaufarb Complaint”) in the U.S. District Court for the Southern District of New York against the same defendants as those named in the Hirani Complaint as well as Lior Danziger and J.B. Lowe. The Blaufarb Complaint makes largely the same allegations as those in the complaint in the Consolidated Securities Litigation and seeks declaratory relief, corporate governance reforms, damages, restitution, attorneys’ fees, and other relief. It also pleads the same counts as those in the Hirani Complaint, as well as additional counts for abuse of control and gross mismanagement. The Hirani and Blaufarb actions, with the Hirani matter designated as the lead case (together, the “Consolidated Derivative Actions”). On June 20, 2025, the parties agreed that the Consolidated Derivative Actions are stayed through the close of fact discovery in the Consolidated Securities Litigation.

On August 7, 2024, Edwin Isaac filed a purported derivative complaint (the “Isaac Complaint”) in the U.S. District Court for the District of Delaware against the same defendants as those named in the Consolidated Derivative Actions. The Isaac Complaint makes largely the same allegations as those in the Consolidated Securities Litigation. It also pleads the similar counts to those in the Consolidated Securities Litigation, including (i) breach of fiduciary duty, (ii) contribution, (iii) violation of Section 14(a) of the Exchange Act and SEC Rule 14a-9, (iv) unjust enrichment, (v) waste of corporate assets, and (vi) aiding and abetting breach of fiduciary duty. The complaint seeks declaratory relief, damages, interest, unspecified equitable relief, attorneys’ fees, and other relief. The parties are conferring on service of process and a possible stay of proceedings pending resolution of the motion to dismiss in the Consolidated Securities Litigation. On June 30, 2025, the parties agreed to stay the Isaac matter through the close of fact discovery in the Consolidated Securities Litigation.

On May 22, 2025, Mike Maddox (a purported shareholder) filed a derivative complaint (the “Maddox Complaint”) in the U.S. district Court for the Southern District of New York against the same Defendants as those named in the Consolidated Derivative Actions and in the Isaac matter. The Maddox Complaint makes largely the same allegations as those in the Consolidated Securities Litigation, the Consolidated Derivative Actions, and the Isaac matter. It also pleads similar counts to those in the Consolidated Derivative Actions and the Isaac matter, including (i) breach of fiduciary duty, (ii) gross mismanagement, (iii) waste of corporate assets, (iv) unjust enrichment, and (v) violation of Section 14(a) of the Exchange Act. The parties agreed to stay the Maddox matter through the close of fact discovery in the Consolidated Securities Litigation. Due to the early stage of these proceedings, the Company cannot reasonably estimate the potential range of loss, if any, or the likelihood of a potential adverse outcome. The parties filed a stipulation on July 21, 2025, agreeing to stay the Maddox Complaint through the close of fact discovery in the Consolidated Securities Litigation.

On September 3, 2025, Jerald F. Chauncey, Jr. filed a derivative complaint (the “Chauncey Complaint”) in the court of Chancery in the state of Delaware, against the same Defendants as those named in the Consolidated Derivative Actions and in the Isaac and Maddox matters. The Chauncey Complaint makes largely the same allegations as those in the Consolidated Securities Litigation, the Consolidated Derivative Actions, and the Isaac and Maddox matters. It also pleads similar counts to those in the Consolidated Derivative Actions and the Isaac matter, including (i) breach of fiduciary duty, (ii) unjust enrichment, and (iii) waste of corporate assets. The Company disputes the allegations of wrongdoing and intends to vigorously defend against them. On October 7, 2025, the court granted the parties joint motion to stay the Chauncey Complaint through the close of fact discovery in the Consolidated Securities Litigation.

On January 13, 2025, Stellantis Europe S.p.A. (“Stellantis”) submitted an application for injunctive relief, to the Court of Turin, Italy, claiming that SolarEdge e-Mobility was allegedly in breach of contract. The application for injunctive relief is aimed at obtaining the following interim measures: i) order the Company to resume supply of spare parts and technical assistance activities in favor of Stellantis; and ii) to order the Company to pay a penalty of 100,000 Euro for each day of delay in fulfilling the order above. At a hearing on February 25, 2025 the parties discussed the case. On May 8, 2025, the court denied Stellantis’ request for injunction and on May 23, 2025 Stellantis appealed. The Company disputes the allegations of wrongdoing and intends to vigorously defend against them.

On September 15, 2025, Ampt, LLC (“Ampt”) filed a lawsuit in the District of Delaware seeking to enforce an agreement between Ampt and the Company. The Company had invoked a force majeure clause in relation to its performance of the agreement, valued at $54 million over a period of five years, in October 2023. The Company has not yet filed an answer, the case remains in its very preliminary stages, and it is too early to reasonably determine the outcome of the lawsuit. The Company disputes the allegations and intends to vigorously defend against them.

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2025	Nov. 01, 2025
Cover [Abstract]
Entity Registrant Name	SOLAREDGE TECHNOLOGIES, INC.
Entity Central Index Key	0001419612
Document Type	10-Q
Document Period End Date	Sep. 30, 2025
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q3
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-36894
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5338862
Entity Address, Country	IL
Entity Address, City or Town	Herziliya Pituach
Entity Address, Address Line One	1 HaMada Street
Entity Address, Postal Zip Code	4673335
City Area Code	972
Local Phone Number	(9) 957-6620
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Title of each class	Common stock, par value $0.0001 per share
Trading Symbol	SEDG
Name of Exchange on which Security is Registered	NASDAQ
Entity Common Stock, Shares Outstanding		59,800,051

INVENTORIES, NET

9 Months Ended

Sep. 30, 2025

Inventory Disclosure [Abstract]

INVENTORIES, NET

NOTE 3: INVENTORIES, NET

	September 30, 2025		December 31, 2024
Raw materials	$	280,349	$	209,259
Work in process		-		3,113
Finished goods		250,450		433,525
Total inventories, net	$	530,799	$	645,897

STOCK CAPITAL (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan	10,000,000		10,000,000
Equity based compensation expenses to employees and nonemployees	$ 0	$ 0	$ 0	$ 0
Unrecognized compensation expense	$ 141,367		$ 141,367
2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future grant under the plan	12,318,881		12,318,881
Share-Based Payment Arrangement, Option [Member] \| 2015 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan	26,648,950		26,648,950
Number of shares available for future grant under the plan	8,699,806		8,699,806
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan	5,125,666		5,125,666
Maximum percentage of salary	15.00%		15.00%
Aggregate limit per participant			$ 15,000
Purchase price of common stock, percent			85.00%
Stock Repurchased During Period, Shares			2,311,170
Number of shares available for future grant under the plan	2,814,496		2,814,496

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2025
Income Taxes [Abstract]
INCOME TAXES	NOTE 18: INCOME TAXES For the three months ended September 30, 2025, the Company reported income taxes at an effective tax rate of negative 5.4% including discrete items, compared to the three months ended September 30, 2024, where the Company reported income taxes at an effective tax rate of negative 10.9%. For the nine months ended September 30, 2025, the Company reported income taxes at an effective tax rate of negative 5.4% including discrete items, compared to the nine months ended September 30, 2024, where the Company reported income taxes at an effective tax rate of negative 5.9%. The negative effective tax rate in the three and nine months ended September 30, 2025 resulted primarily from the valuation allowance on current losses and capital losses, coupled with profits in certain jurisdictions and an increase in the provision for uncertain tax positions. The effective tax rate in the corresponding periods in 2024 was mainly caused by the valuation allowance the Company booked on its losses and deferred tax assets to date, impairments and disposals. Deferred tax assets are evaluated for future realization and reduced by a valuation allowance to the extent that the Company believes they will not be realized. The Company considers all available evidence, including historical information, long range forecast of future taxable income and evaluation of tax planning strategies. Amounts recorded for valuation allowance can result from a complex series of judgments about future events and can rely on estimates and assumptions. Based primarily on the negative evidence outweighing the positive evidence, including the Company's three year cumulative, consolidated GAAP loss, historical tax losses and the difficulty in forecasting excess tax benefits related to equity-based compensation, the Company believes there is uncertainty as to when it will be possible to utilize certain net operating losses (each an “NOL”), credit carryforwards, capital losses and other deferred tax assets. Therefore, the Company recorded a valuation allowance against the deferred tax assets for which it is more-likely-than-not they will not be realized. Should the Company's operating results improve and projections show continued utilization of the tax attributes, the Company would consider that as significant positive evidence and future reassessment may result in the determination that all or a portion of the valuation allowance is no longer required. If this were to occur, any reversal of the valuation allowance would result in a corresponding non-cash income tax benefit, thereby increasing total deferred tax assets. In July 2025, the One Big Beautiful Bill Act, or H.R.1 was enacted into law modifying clean energy tax credits contained in the Inflation Reduction Act ("IRA") and imposing new eligibility criteria related thereto. The Company does not expect the H.R.1 to have a material effect on its financial position or results of operations. The Company will continue to monitor regulatory guidance and developments and will update its analysis as necessary. On October 1, 2025, the Governor of California signed Senate Bill 302 (“SB 302”) into law. SB 302 provides a gross income exclusion for taxpayers that either elect to receive direct payments from the Internal Revenue Service or receive payment from transfer of certain federal tax credits beginning tax years on or after January 1, 2026, and before January 1, 2031. The Company is currently evaluating the impact of SB 302 will have on its results of operations in future years.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

RESTRUCTURING AND OTHER EXIT ACTIVITIES (Schedule of Liability Balance for the Restructuring and Other Exit Charges) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2025 USD ($)
Employee termination costs [Member]
Restructuring Reserve [Roll Forward]
Balance as of December 31, 2024	$ 1,073
Charges	4,376
Cash payments	(5,449)
Non-cash utilization and other	0
Balance as of September 30, 2025	0
Contract termination and other [Member]
Restructuring Reserve [Roll Forward]
Balance as of December 31, 2024	23,933
Charges	(16,473)
Cash payments	(6,315)
Non-cash utilization and other	(1,145)
Balance as of September 30, 2025	$ 0

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.

+ References + Details

OTHER LONG TERM ASSETS

9 Months Ended

Sep. 30, 2025

Other Assets, Noncurrent [Abstract]

OTHER LONG TERM ASSETS

NOTE 5: OTHER LONG TERM ASSETS

	September 30, 2025		December 31, 2024
Cloud computing arrangements	$	38,764	$	29,366
Investments in privately held companies		6,375		20,976
Severance pay fund		-		9,185
Prepaid expenses and other		1,214		5,209
Total other long term assets	$	46,353	$	64,736